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ABSTRACT
Th e protein coding information in our genome is located on genes which are very oft en 
interrupted by non-coding regions called introns. For proper gene expression, introns must 
be removed accurately and the remaining protein coding parts, the exons, must be rejoined. 
Th is reaction, termed splicing, is carried out by an enormous macromolecular machine called 
the spliceosome, and is one of the most crucial steps in gene expression. Two diff erent intron 
types have been identifi ed in eukaryotes, each removed by their own dedicated spliceosome: 
the U2-type (or major) introns, which constitute the majority of introns, and the U12-type (or 
minor) introns, of which ca. 700-800 have been identifi ed in the human genome. Th e presence 
of a second type of intron and spliceosome has always been enigmatic. However, studies 
investigating U12-type intron removal have provided us with an important clue; it appears 
that U12-type introns are spliced less effi  ciently than U2-type introns. Th is suggests that their 
removal could be rate-limiting for the expression of the genes that harbor these introns, and it 
also off ers the intriguing possibility that the activity of the minor spliceosome could be altered in 
response to changing cellular conditions. Th ese implications could off er a valuable explanation 
for the extraordinary conservation of the U12-type introns and the components that catalyze 
their excision.
Th ere is currently not much known about the regulation of the minor spliceosome and this 
study aimed to address this issue. I have investigated the characteristics of a negative feedback 
loop that regulates the expression level of two essential and unique protein components of the 
minor spliceosome, the U11-48K and the U11/U12-65K proteins. In the genes that encode 
these proteins, an ultraconserved sequence element can be found which consists of a tandem 
repeat of U12-type 5  ´splice sites. We uncovered that binding of U11/U12 di-snRNPs on these 
elements leads to alternative splicing where an mRNA isoform is produced that is targeted for 
degradation or nuclear retention. Th e presence of such enhancer elements is conserved from 
plants to animals, highlighting an extreme selection pressure for this regulatory mechanism. I 
further investigated the role of the U11-35K protein, another protein uniquely associated with 
the minor spliceosome, in alternative splicing, and the functional requirements for enhancer 
binding. Furthermore, I uncovered the molecular mechanism by which the level of translational-
competent U11/U12-65K mRNA is downregulated through U11/U12 di-snRNP enhancer 
binding.
viii
11.  REVIEW OF THE LITERATURE
1.1  Introns
Unknown to science before 1977, the discovery of eukaryotic intragenic regions that were not 
part of the fi nal mRNA was truly dogma-shattering (Gilbert, 1978). Rather than consisting of 
one continuous sequence, the genetic information of many eukaryotic genes was found to be 
spread out onto pieces that must be accurately joined together in a process called splicing (Berget 
et al., 1977, Chow et al., 1977). Since then, the presence of the interrupting regions, the so-called 
introns, has been shown to provide an additional layer of biological complexity as alternative 
splicing generates multiple proteins from a single gene. Crucial to our understanding of gene 
evolution, disease, and mRNA processing, the discovery of “split genes” led to the 1993 Nobel 
Prize in Physiology or Medicine for Phillip Sharp and Richard Roberts. 
1.1.1  Defi ni? on and Classifi ca? on
Introns are nucleotide sequences that interrupt the coding regions of protein coding genes and 
the functional regions of RNA genes. As such, they can be found in various types of RNA (tRNA, 
rRNA, mRNA and lncRNA) in eukaryotic, viral, organelle, archaeal and bacterial genomes but 
their abundance, size and their mechanism of removal diff ers substantially across the lineages. In 
order to generate a functional protein or RNA product, introns need to be accurately removed 
and the remaining pieces, called exons, joined to one another. Th is process is called RNA 
splicing. On the basis of intron sequence, as well as the biochemical properties of the splicing 
reaction, four main intron classes can be distinguished.
1.1.1.1  Spliceosomal Introns
Spliceosomal introns constitute the predominant class of eukaryotic introns and their removal 
is catalyzed by dedicated ribonucleoprotein complexes called spliceosomes. Two diff erent 
spliceosomes can be found in eukaryotic organisms: the major (or so-called U2-dependent) 
spliceosome and the minor (or so-called U12-dependent) spliceosome. Whereas the major 
spliceosome catalyzes the removal of the majority of introns, the minor spliceosome targets a 
specifi c and rare class of spliceosomal introns: the minor (or U12-type) type intron. Apart from 
their diff erential prevalence, the two intron types have distinct recognition sequences (“splice 
sites”), and both the composition of the spliceosome machinery and the mechanism of intron 
removal diff er (see 1.2).
Th e most crucial pieces of information that introns possess are located on recognition 
sequences at the very 5´ and 3´ ends of the intron, which can extend a few nucleotides (nt) into 
the fl anking exons. Th ese so-called 5´ and 3´ splice sites (ss) are recognized by components of 
the spliceosomal machinery. Th e spliceosome recognizes another sequence motif, the so-called 
branch point sequence (BPS), typically located 20-40 nt upstream of the 3´ ss and containing 
the crucial adenosine that is required for the fi rst nucleophilic attack of the splicing reaction 
(Ruskin et al., 1984). In most metazoa, the BPS is followed by a polypyrimidine tract (PPT), a 
pyrimidine-rich motif crucial for effi  cient BPS utilization and selection. Both the length and the 
sequence of the PPT are fl exible (Coolidge et al., 1997). 
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2Figure 1. Splice site consensus sequences for U12-type (A) and U2-type (B) introns. Adapted from 
Turunen et al. (2013a).
In the case of the U2-type intron, the consensus 5´ ss is AG/GTAAGT, the slash denoting exon-
intron boundary and the consensus 3´ ss is YAG/G (Fig. 1b). In higher eukaryotes, these splice 
sites are highly degenerate with the exception of the terminal dinucleotides, which are almost 
always GT-AG (Aebi et al., 1986). Th e most frequent exception, comprising 0.9 % of all U2-type 
introns, are those introns that have GC-AG dinucleotides at their exon-intron boundaries (Sheth 
et al., 2006). Other subtypes are extremely rare: in the human genome, 15 cases of AT-AC introns 
can be found (Sheth et al., 2006). In more basal and more intron-poor eukaryotic groups, the 
5´ ss is much more conserved: perhaps a compensation mechanism for a lack of exonic splicing 
signals (Irimia et al., 2007, Irimia et al., 2009). Th e human BPS is a highly degenerative yUnAy 
and the sequence context, in addition to the presence of the PPT, is important for its utilization 
(Gao et al., 2008). In contrast, yeast introns have a strictly conserved consensus BPS, UACUAAC, 
and generally lack a PPT (Coolidge et al., 1997). 
On the other hand, the U12-type consensus 5´ ss is a highly conserved /RTATCCTTT, with a 
purine residue (R) at the +1 position relative to the exon-intron boundary (Fig. 1a). Th e terminal 
nucleotides at the 5´ and 3´ end of the U12-type intron show high interdependence (Dietrich 
et al., 2005) such that two diff erent varieties can be distinguished: the GT-AG and the AT-AC 
classes, of which the GT-AG class is the most common in human (ca. 76 %: Sheth et al. (2006)). 
Th e U12-type BPS consists of an 8 nt pyrimidine-rich sequence, followed by the branch point 
adenosine either in position 9 or 10 (McConnell et al., 2002) and then a further 2 nt enriched in 
pyrimidines. Th e distance of the BPS to the 3´ ss is generally short (10-20 nt) (Sharp and Burge, 
1997) but can be, at least for the GT-AG subtype, extended to more than 35 nt (Dietrich et al., 
2005). U12-type introns lack a PPT, further hinting, together with the obvious dissimilarities 
in splice sequence motifs, to a fundamental diff erence in intron recognition between the two 
spliceosomes.
Genes of multicellular organisms are generally intron-rich. In human, the average gene 
contains about 7.8 introns (Sakharkar et al., 2004) and the expression of the monstrous titin 
gene requires the correct removal of no less than 362 introns (Bang et al., 2001). In contrast, 
about 3 % of all human genes contain no introns at all, primarily those encoding for G-protein 
coupled receptors and histones (Louhichi et al., 2011). Within the eukaryotic lineage there is 
signifi cant variation in intron density: Caenorhabditis elegans has 4.7 introns per gene (Schwarz 
et al., 2006), Arabidopsis thaliana has 4.4 (Haas et al., 2005) and Drosophila melanogaster has 
3.4 (Drysdale et al., 2005). At the opposite end of the spectrum, the fungus Encephalitozoon 
cuniculio, the nucleomorph of the alga Guillardia theta, and the protozoan parasite Giardia 
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lamblia all have very few introns: respectively 15, 17 and 4 (Jeff ares et al., 2006, Morrison et 
al., 2007). Spliceosomal introns seem to be completely lost from the parasitic microsporidian 
Enterocytozoon bieneusi and in the nucleomorph genome of Hemiselmis andersenii (Lane et al., 
2007, Keeling et al., 2010). It is tempting to associate increasing intron density with increasing 
“biological complexity”, but the variation observed in fungi troubles that assumption. Whereas 
the yeasts Schizosaccharomyces pombe (0.9 introns per gene) and, especially, Saccharomyces 
cerevisiae (0.05 per gene) show low intron densities (Wood et al., 2002, Hirschman et al., 
2006), the basidiomycete Cryptococcus neoformans displays intron densities similar to many 
multicellular eukaryotes (5.3 per gene) (Loft us et al., 2005). Furthermore, two early branching 
protists, the jakobids and the malawimonads, possess a large number of introns (Archibald et al., 
2002). Clearly, widespread intron gain or intron loss, or a combination thereof, must have taken 
place at multiple times during evolution.
U12-type introns are very rare: about 0.4 % of human introns are of the U12-type (Sheth 
et al., 2006), and Drosophila melanogaster, for example, harbors only 19 U12-type introns (Lin 
et al., 2010). Th ey are present in many eukaryotic lineages: vertebrates, cnidarians, insects, 
plants and even protists (Burge et al., 1998, Russell et al., 2006), suggesting an early evolutionary 
origin. Th ey are however absent and thought to be lost in Caenorhabditis elegans, Saccharomyces 
cerevisiae and Schizosaccharomyces pombe (Burge et al., 1998). Typically, within those genes that 
harbor U12-type introns, a single U12-type intron is found, surrounded by U2-type introns. 
Interestingly, several genes exist that have two, and in a single case even have three U12-type 
introns (Burge et al., 1998, Levine and Durbin, 2001). 
Between diff erent lineages, the average size of introns varies greatly. In protozoa, intron 
length rarely exceeds 100 nt (Wu et al., 2013). Th e introns of Encephalitozoon cuniculi are 
extremely short (23-52 nt) and the pygmy introns of the nucleomorph genome of Bigelowiella 
natans are the smallest known (18-21 nt) (Gilson et al., 2006, Lee et al., 2010). Saccharomyces 
introns are on average 266 nt long (Bon et al., 2003), and the length of Arabidopsis thaliana 
and Drosophila melanogaster introns is on average 158 nt and 818 nt, respectively (Hong et al., 
2006). Vertebrate introns seem to have been expanding: the average human intron is 3749 nt 
long, comparable to that of other vertebrates (Hong et al., 2006, Wu et al., 2013). One notable 
exception are the puff er fi sh, amongst which Tetraodon rubripes has one of the most compact 
vertebrate genomes, partly due to a reduction in intron size (435 nt on average) (Guo et al., 2010). 
Th e nature of the gene itself can shape the length of the introns it harbors: in humans, introns 
of highly expressed genes and housekeeping genes are shorter than those of genes expressed at 
low levels. A possible explanation is that, since transcription is both time and energy consuming, 
selective forces might act to reduce intron length in highly expressed genes (Eisenberg and 
Levanon, 2003, Urrutia and Hurst, 2003). Even within a single gene there are diff erences: introns 
within the 5´ untranslated region (5´ UTR) and the fi rst intron within the coding region are 
typically longer than those located downstream (Bradnam and Korf, 2008). First introns show 
more sequence conservation relative to other introns (Keightley and Gaff ney, 2003) and have 
shown to be enriched in regulatory motifs (Majewski and Ott, 2002, Gaff ney and Keightley, 
2004), partly explaining their increased lengths.
Th e size of U12-type introns is comparable to that of U2-type introns (Levine and Durbin, 
2001). However, in comparison to U2-type introns, in the length distribution of U12-type 
introns, there seems to be no enrichment for short introns (ca. 90 nt) (Levine and Durbin, 2001) 
and this might indicate a preference for exon defi nition mediated splice site recognition of U12-
type introns (Patel and Steitz, 2003) (see 1.2.2 for a discussion of exon defi nition).
41.1.1.2  tRNA Introns
Another type of introns, whose removal is completely based on protein components, can 
be found in tRNA precursors in two major lines of descent: the archaea and the eukaryotes 
(Abelson et al., 1998). Introns are also present in bacterial tRNA but they are self-splicing and 
belong to a diff erent class (group I introns, see 1.1.1.3). Introns in tRNA were fi rst described 
in Saccharomyces cerevisiae (Goodman et al., 1977, Valenzuela et al., 1978) where 59 of the 256 
tRNA genes are interrupted by introns (Trotta et al., 1997). Th ey show no obvious sequence 
conservation at their splice sites, are 14-60 nt in length and are located immediately 3´ to the 
anticodon (Ogden et al., 1984). Th eir removal depends solely on protein components and 
occurs in a 3-step mechanism (Fig. 2a, and Abelson et al. (1998)). In the fi rst step, the tRNA 
endonuclease cleaves the intron at the splice sites. Since there is no sequence conservation at 
the splice sites, recognition occurs by measuring the distance from the mature domain of the 
tRNA to the splice site (Reyes and Abelson, 1988). In addition to this ruler-mechanism, some 
sequences within the intron itself can assist the recognition (Baldi et al., 1992, Di Nicola Negri 
et al., 1997). In a second step, tRNA ligase joins the ends in a reaction that is dependent on ATP 
hydrolysis (Abelson et al., 1998). Ultimately, the 5´ ss is dephosphorylated by a nicotinamide 
adenine dinucleotide- (NAD-) dependent phosphotransferase (McCraith and Phizicky, 1991). In 
archaea, tRNA introns are small and the splice sites are recognized because they are located in a 
conserved structural motif, the bulge-helix-bulge (BHB) motif (Th ompson and Daniels, 1988). 
Archaea operate by a similar pathway for tRNA intron removal: both tRNA endonucleases and 
tRNA ligases are present (Yoshihisa, 2014). Th e presence of such introns seems to be a restriction 
for the function of the tRNA and there is no conclusive explanation for their role. However, 
certain tRNA introns are known to contain motifs that promote tRNA modifi cation (Grosjean et 
al., 1997), perhaps driving selection pressure for intron maintenance.  
1.1.1.3  Group I Introns
In the genomes of bacteria, bacteriophages, mitochondria, chloroplasts, some eukaryotic viruses 
and lower eukaryotes, a third class of introns can be found that interrupts rRNA, mRNA and 
tRNA species (Cech, 1986, Haugen et al., 2005). Interestingly, these so-called group I introns 
are absent from nuclear genomes in multicellular organisms. Group I introns are self-splicing 
ribozymes but some do rely to varying degrees on protein factors (Nielsen and Johansen, 2009). 
Th ey show little conservation at the sequence level, however, the last nucleotide of the upstream 
exon is very oft en a U, and the last nucleotide of the intron sequence is a G (Nielsen and Johansen, 
2009). Th ey are on average 250-500 nt long and consist of nine paired regions folding into helical 
domains (Woodson, 2005, Haugen et al., 2005). Th eir removal occurs through two coupled 
transesterifi cation reactions where a 3´ hydroxyl group of an exogenous guanosine attacks the 
phosphodiester bond at the 5´ ss. Th e resulting free hydroxyl group at the upstream exon then 
attacks the 3´ ss, leading to ligation of the exons and intron release (Fig. 2b, and Cech (1990)). 
So far, no clear biological role has been attributed to group I introns: they seem to be selfi sh 
genetic elements with their self-splicing ability rendering them relatively neutral to the host. On 
the other hand, it has been suggested that they could regulate expression of rRNA and protein 
coding genes (Nielsen and Johansen, 2009), and assist in the correct folding of their tRNA and 
rRNA exons (Cao and Woodson, 2000, Rangan et al., 2004). 
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51.1.1.4  Group II Introns
In bacterial genomes and the organelle genomes of certain eukaryotes (fungi and plants in 
particular), a remarkable mobile genetic element can be found. Th ey are called group II introns 
and they combine the ability to self-splice with, through the reverse transcriptase activity of an 
intron-encoded protein (IEP), the ability to invade and to populate new DNA sites (Lambowitz 
and Zimmerly, 2011). Group II introns are characterized by a 400-800 nt long conserved 
sequence, consisting of 6 domains that fold such that distant sites are brought together to form 
an active site. Th is structure binds the splice sites and a branch-point nucleotide, and uses 
Mg2+ ions for catalysis (Lambowitz and Zimmerly, 2011). As is the case with group I introns, 
a two-step transesterifi cation drives their splicing reaction (Fig. 2c, and Peebles et al. (1986)): a 
nucleophilic attack from the 2´ hydroxyl of the bulged branch point adenine to the 5´ ss, leading 
to the formation of an intron lariat-3´ exon intermediate. Th is is followed by the nucleophilic 
attack of the 3´ hydroxyl of the cleaved 5´ exon to the 3´ ss, resulting in lariat release and exon 
ligation. Th e multifunctional IEP that is encoded within group II introns both promotes the 
splicing reaction (Carignani et al., 1983), and reverse transcribes the excised intron which, 
through its ribozyme activity, can reverse splice into DNA. As such, group II introns are highly 
mobile elements and are thought to have shaped the genomic evolution of eukaryotes (Sharp, 
1985, Cech, 1986, Zimmerly et al., 1995). Th ey are absent from eukaryotic nuclear genomes, 
where mechanisms might have evolved that stopped their proliferation. Specifi cally, eukaryotic 
nuclei have low Mg2+ concentrations, incompatible with the high concentrations required for the 
catalysis of group II splicing (Lambowitz and Zimmerly, 2011, Truong et al., 2013). In addition, 
group II introns are believed to be the ancestors of both spliceosomal introns (Cech, 1986, Burge 
et al., 1998): their splicing pathways are identical (see 1.2.3, and Fig. 2), and there are structural 
similarities between spliceosomal RNAs and critical domains of group II introns (Madhani and 
Guthrie, 1992, Shukla and Padgett, 2002, Toor et al., 2008, Dayie and Padgett, 2008, Pyle, 2010). 
Furthermore, the 5´ and 3´ ends of group II introns have conserved sequences, GUGYG and AY, 
respectively, which are remarkably similar to those of spliceosomal introns. 
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6Figure 2. Splicing mechanisms for the four diff erent intron classes. tRNA introns (A), group I introns 
(B), group II introns (C), and spliceosomal introns (D). Aft er Cech (1990).       
            
1.1.2  On the Origin of Introns
Our genomes are crowded with spliceosomal introns: in human, several hundred thousands 
have been identifi ed (Sakharkar et al., 2004). Where do they come from? Because of reasons 
discussed in 1.1.1.4, it seems reasonable to assume that spliceosomal introns were derived from 
self-proliferating and self-splicing selfi sh genetic elements, the group II introns, which then lost 
their ability to self-splice and subsequently increased their dependence on trans-acting factors. 
Th e presence of spliceosomal introns is a universal feature of even the most basal eukaryotic 
genomes but they are missing from archaeal and bacterial genomes. Based on their omnipresence 
in eukaryotic genomes (Jeff ares et al., 2006, Morrison et al., 2007) and the conservation of intron 
positions in orthologous genes of much diverged lineages (Marchionni and Gilbert, 1986), it 
is clear that spliceosomal introns are ancient but the timing of their appearance is the subject 
of intense debate in which two main theories have been proposed. Th e introns late theory 
(Cavalier-Smith, 1985, Palmer and Logsdon, 1991) postulates the appearance of introns within 
the eukaryotic lineage, where inserted transposable elements and reverse splicing formed sources 
of new introns. Th e introns early model (Darnell, 1978) counters that introns were present 
already in the last universal common ancestor (LUCA), and promoted, through recombination 
within intronic sequences, the formation of new gene products in a process called exon shuffl  ing 
(Gilbert, 1978). Introns have since then been lost in the prokaryote and archaeal lineages due 
to a need for streamlining their genome for shorter replication times and/or due to their large 
population sizes (Lynch and Richardson, 2002). 
Although proponents of each theory persist, the current general consensus can be interpreted 
as a compromise: spliceosomal introns appeared at the time of the origin of eukaryotes (kind of 
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7late), and are descendants from pre-existing self-splicing introns. A more suggestive hypothesis 
puts forward the notion that, during the endosymbiosis event in which mitochondria were 
acquired, spliceosomal introns originating from α-proteobacterial group II introns transferred 
to the host genome (Cavalier-Smith, 1991). Recent comparisons amongst eukaryotes provide 
evidence that the ancestors of the last eukaryote then experienced a dramatic increase in introns 
(Koonin, 2009). Selection then drove these early organisms to compartmentalize their genome 
into a nucleus to stop proliferation of the self-replicating introns (perhaps due to the lower Mg2+ 
levels), and to fragment the group II introns into spliceosomal small nuclear RNAs (snRNAs) 
with increasing reliance on protein factors. Such fragmentation into trans-acting factors might 
have promoted the loss in group II introns, as any mutation aff ecting their self-splicing abilities 
could be compensated if the proto-spliceosome were able to recognize the intron boundaries 
(Stoltzfus, 1999). In addition, a trans-acting spliceosomal system would relieve the mutational 
pressure on a system where the genome is crowded with group II introns for which the number 
of constrained nucleotides is very high (Lambowitz and Zimmerly, 2011, Irimia and Roy, 2014). 
Given that the intron densities diff er by orders of magnitude in diff erent lineages, from these 
ancient ancestors on, there have been diff erent rates of intron loss (and gain) in the diverse 
lineages (Rogozin et al., 2003). 
1.1.2.1  Intron Gain and Intron Loss
A great number of introns was already present in the ancestral genome (Carmel et al., 2007). 
Comparisons of exon-intron structures between highly conserved genes suggest that both 
signifi cant intron loss and gain have occurred during eukaryotic gene evolution (Rogozin et al., 
2003). Remarkably, introns have been gained recently in the rab4 gene within a small Daphnia 
pulex population endemic to Oregon (Omilian et al., 2008), and an intron has been acquired in 
the primate-specifi c RNF113B retrogene in human only (Szczesniak et al., 2011), showing that 
intron gain can be a recent evolutionary phenomenon. 
Th e mechanism behind intron gain events could be through a process similar to group II 
intron retro-transposition (Sharp, 1985), in which a reverse splicing event is combined with 
reverse transcription. Additionally, transposable elements could, under certain conditions, give 
rise to spliceosomal introns (Purugganan and Wessler, 1992). Another mechanism is the tandem 
duplication of sequences containing an AGGT tetramer where de novo 5´ and 3´ splice sites are 
created with retention of the reading frame aft er intron removal (Rogers, 1989). Th is model 
predicts that introns produced by such duplication event will display sequence similarity at their 
boundaries. Th ere might be evidence for such proliferation at the intron-exon boundaries of the 
U12-type AT-AC class in the human genome: the two most common nucleotides at positions -2 
and -1 of the 5´ exon are A and C, respectively, and the 4 most common nucleotides at positions 
+1, +2, +3 and +4 of the 3´ exon are A, T, A and T respectively (data obtained from Splicerack 
database: Sheth et al. (2006)). Th is raises the possibility that initial proliferation of these 
introns could be achieved by tandem replication of a sequence ACATATCCT. Th e weakness of 
this hypothesis is that it would require the fortuitous presence of a BPS within the duplicated 
sequence, which, in the case of the minor spliceosome, is a rather conserved sequence element. 
Massive intron losses, on the other hand, seem to be the dominant outcome for many lower 
eukaryotes. Here, mechanisms of intron loss include but are not limited to, reverse transcription 
of processed mRNA followed by gene conversion, and simple genomic deletion (Palmer and 
Logsdon, 1991, Lynch and Richardson, 2002).
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Ever since the discovery of the U12-type intron and its spliceosome (Jackson, 1991, Hall and 
Padgett, 1994, Tarn and Steitz, 1996b, Sharp and Burge, 1997), one of the most intriguing aspects 
was their origin. U12-type introns, albeit rare, can be found in diverse eukaryotic lineages and 
were, highly likely, already present in the last eukaryotic common ancestor (LECA) (Russell et 
al., 2006). One of the earliest hypotheses concerning their origin is the fi ssion-fusion model 
(Burge et al., 1998), where it was postulated that spliceosomal U12-type and U2-type introns 
were derived from a common ancestor. Speciation of two separate lineages, each with their own 
spliceosome and intron-type, occurred and was then perhaps followed by endosymbiosis, where 
their genetic material was fused. Over time, the vast majority of the acquired U12-type introns 
were then converted into U2-type introns because, due to the severe sequence constraints 
imposed on the U12-type splice site sequences, the reciprocal conversion is an unlikely event. 
Th is model is supported by the observation that there are more genes with multiple U12-type 
introns than expected by chance, and by the presence of paralogous genes with U12-type 
introns in non-homologous positions so that diff erent sets of U12-type introns were either lost 
or converted (Burge et al., 1998). However, the model has been criticized as to what extent an 
organism could survive and reproduce aft er undergoing such a radical fusion event (Lynch and 
Richardson, 2002). A study of the amino acid distribution at intron-containing sites that are 
subject to extreme evolutionary constraints revealed that primordial spliceosomal introns were 
probably of the U2-type (Basu et al., 2008b). Here, a scenario is suggested in which two separate 
group II intron invasions took place into the early eukaryotic ancestor, in which the U2-type 
introns would be the fi rst to populate the genome followed by a smaller-scale invasion of U12-
introns. 
Whatever the scenario, it is evident that, since those early events, there has been massive 
loss of U12-type introns, at least in invertebrates (Lin et al., 2010), or even complete loss, as is 
the case in some yeasts and Caenorhabditis elegans (Burge et al., 1998, Bartschat and Samuelsson, 
2010). Interestingly, U12-type introns are lost to a much greater degree than they are converted 
to U2-type introns (Lin et al., 2010). Why have they not yet been completely purged from our 
genomes? Th e answer might lie in the fact that U12-type intron loss and/or conversion can be a 
relatively slow process for certain organisms, and only obtainable by organisms where population 
size and generation time are high and short enough, respectively, so that genome streamlining 
can occur. On the other hand, both the conservation of U12-type introns in the gene encoding 
the sodium channel α-subunit between humans and jellyfi sh (somehow withstanding loss or 
conversion to U2-type) (Wu and Krainer, 1999, Patel and Steitz, 2003) and the fact that U12-
type intron positions are more conserved than U2-type intron positions between Arabidopsis 
thaliana and human (Basu et al., 2008a), are remarkable observations and highly indicative of a 
functional role for the U12-type intron. 
1.1.3  What good is an Intron?
Seemingly, the presence of introns can be considered a burden for the cells. Indeed, for most 
genes, only a minority of transcribed nucleotides will eventually code for protein and, with 
introns ranging up to several hundreds of thousands of nucleotides long, the interruption 
of our genetic material seems wasteful and energy-consuming. For proponents of the introns 
early theory, introns have already served us well by allowing for a process called exon shuffl  ing, 
in which exons from diff erent genes can combine and give birth to new genes. Whether they 
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genetic elements ever since. Virtually every eukaryotic genome harbors spliceosomal introns and 
it is highly probable that, if introns suddenly somehow were to disappear, mass extinction at 
the eukaryotic domain would be the unfavorable outcome. In fact, RNA splicing is intimately 
linked with almost every known process in the mRNA maturation pathway (Maniatis and Reed, 
2002). Splicing factors are connected with elongation factors to promote transcription activation 
(Fong and Zhou, 2001), and RNA splicing promotes effi  cient mRNA export to the cytoplasm 
(Luo and Reed, 1999) as well as effi  cient cleavage and polyadenylation of the transcript (Dye and 
Proudfoot, 1999, Vagner et al., 2000b). In addition, RNA splicing and associated components 
enable an extensive number of quality control mechanisms: the inhibition of premature cleavage 
of transcripts by the U1 snRNP (Kaida et al., 2010, Berg et al., 2012), ensuring nuclear retention 
of potentially toxic unspliced pre-mRNAs (Dreyfuss et al., 2002), and tagging transcripts that 
contain premature termination codons for destruction by the nonsense mediated decay (NMD) 
pathway (Lykke-Andersen et al., 2001). 
Introns also off er a practice ground for evolutionary experimentation: they provide space 
for the development of new promoter elements and they can harbor and develop elements that 
regulate gene expression (Chorev and Carmel, 2012). Furthermore, hundreds of intronic nested 
genes (i.e. ORFs located within an external host gene) can be found in the human genome (Yu 
et al., 2005), and introns are the source of many RNA genes such as microRNAs (miRNAs), 
small nucleolar RNAs (snoRNAs), piwi-interacting RNAs (piRNAs), and various long non-
coding RNAs (lncRNAs) (Rearick et al., 2011). Th rough a process called back-splicing, in which 
a downstream 5´ss is joined with a 3´ss of an upstream exon, introns allow the formation of 
circular RNAs (circRNAs) (Nigro et al., 1991, Cocquerelle et al., 1992, Cocquerelle et al., 1993). 
Th e function of these circRNAs is still largely unknown but they have been shown to act as a 
“molecular sponge” to modulate miRNA activity (Hansen et al., 2013, Memczak et al., 2013), and 
are hypothesized to bind and sequester RNA-binding proteins or ribonucleoprotein complexes 
amongst several other suggested functions (reviewed in Hentze and Preiss (2013)). 
Most notably, introns allow for the process of alternative splicing in which novel transcripts 
are produced from a single gene through incorporation of alternative exons or parts of the exons, 
and hence increase proteome diversity (Nilsen and Graveley, 2010). Th ey can regulate alternative 
splicing, not just by their mere existence, but due to the presence of regulatory elements that 
either promote (intronic splicing silencer) or prevent (intronic splicing enhancer) splice site 
activation. In summary, despite being ultimately derived from selfi sh elements and perhaps at 
some point challenging our earliest ancestors to an enormous evolutionary task: introns allow 
for an intricate regulation (the what, when and where) of the genes that harbor them and, as 
such, provide a driving force for the complexity of biological life.
1.2 RNA Splicing and the Spliceosome
Introns are removed and exons are rejoined through the cooperative action of proteins and 
RNAs in what probably is the largest molecular machine in the cell (Nilsen, 2003, Valadkhan 
and Jaladat, 2010): the spliceosome. It faces the enormous task of ensuring the effi  ciency and 
accuracy of the splicing reaction. Furthermore, fl exibility of splice site choice enables the process 
of alternative splicing but appropriate regulation in a time- and space-dependent manner must 
be achieved. Here, we will investigate how the spliceosome tackles these challenges, and the 
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composition and characteristics of its splicing reaction, requiring the coordinated input of as 
many as 150 proteins (Valadkhan and Jaladat, 2010), will be summarized.  
          
1.2.1  Spliceosome Composi? on
Th e spliceosome is a massive ribonucleoprotein, consisting of a core of fi ve small nuclear 
ribonucleic proteins (snRNPs), of which the associated snRNAs are termed U1, U2, U4, U5 and 
U6 snRNA, respectively. With the exception of the U6 snRNA, all snRNAs harbor binding sites 
for Sm proteins that form a seven-member ring-like core structure around the RNA and these 
proteins are crucial for the correct processing and nuclear localization of the snRNA (Kambach 
et al., 1999). Th e U6 snRNA instead, is bound by a set of seven proteins homologous to the Sm 
proteins, the like Sm proteins (Lsm). Th ese form a heptameric Lsm2-8 ring with a similar role as 
the Sm proteins (Spiller et al., 2007). Apart from this set of shared proteins, each of the snRNPs 
also has a specifi c set of protein factors (Will et al., 1993). Important components of the U1 
snRNP include the SR-like protein U1-70K (see 1.2.2), and the U1-A and U1-C proteins, which 
stabilize the interaction of the U1 snRNA with the 5´ ss (Will and Lührmann, 2011). Th e core 
of the U2 snRNP consists of the stably associated U2A´ and U2B´´ polypeptides, as well as the 
heteromeric protein complexes SF3a and SF3b (Will et al., 2002). Th e U4 snRNP and U6 snRNP 
are linked to each other through protein components and extensive base pairing interactions 
to form the U4/U6 di-snRNP (Nottrott et al., 2002). Th e U5 snRNP contains a distinct set of 
proteins, most notably the multifunctional Prp8 protein, and associates through protein factors 
with U4/U6 to form the U4/U6.U5 tri-snRNP, comprising more than 30 proteins (Nguyen et al., 
2015).
Apart from these snRNP associated proteins, there are a large number of protein factors 
that associate with the spliceosome from one stage of splicing to the next (Behzadnia et al., 2007, 
Fabrizio et al., 2009, Will and Lührmann, 2011). Proteins that assist in splice site recognition, 
such as SF1 (splicing factor 1) and U2AF (U2 auxiliary factor), which recognize the BPS, PPT 
and 3´ ss, form an integral part of the spliceosome. A large set of helicases carries out the 
extensive structural and compositional remodeling of the snRNPs that are required during stage 
transitions (Cordin et al., 2012). Several cyclophilins, a subfamily of peptidyl-prolyl cis-trans 
isomerases, facilitate conformational changes within the spliceosome (Th apar, 2015). Kinases 
can modulate protein-protein interactions within the spliceosome (Misteli, 1999). Furthermore, 
various splicing activators and repressors (such as SR proteins and hnRNPs, see 1.2.2.2) that 
play regulatory roles in splicing can associate with the spliceosome in a tissue-, time- or intron-
dependent manner (Will and Lührmann, 2011). Finally, some of the spliceosome-associated 
proteins are crucial for coupling with the machineries of other pre-mRNA processes, such as 
transcription and polyadenylation (reviewed in Maniatis and Reed (2002)).
In the minor spliceosome, the U1, U2, U4 and U6 snRNAs are replaced by the U11, U12, 
U4atac and U6atac snRNAs, respectively, whereas the U5 snRNA is a shared component of both 
spliceosomes (Montzka and Steitz, 1988, Tarn and Steitz, 1996a, Tarn and Steitz, 1996b, Incorvaia 
and Padgett, 1998, Patel and Steitz, 2003). Similarly to major-type snRNAs, Sm proteins form a 
ring around the minor-type snRNAs, with the exception of U6atac which instead binds to Lsm 
proteins, similarly to U6 snRNA (Tarn and Steitz, 1996a). Th e sequences of the U11 and U12 
snRNAs are not homologous to those of U1 and U2, however, their secondary structures show a 
great deal of similarity (Montzka and Steitz, 1988, Patel and Steitz, 2003). Apart from structural 
homology, they also show functional homology: U11 recognizes the U12-type 5´ ss and U12 
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recognizes the U12-type BPS (Hall and Padgett, 1996, Kolossova and Padgett, 1997). Unlike 
their major-type counterparts, U11, which also exists as a mono-particle, and U12 combine to 
a preformed U11/U12 di-snRNP (Wassarman and Steitz, 1992). U4atac and U6atac are ca. 40% 
homologous to their major-type cousins (Tarn and Steitz, 1996a), and they are known to interact 
with one another through base pairing. Th ey associate with U5 to form the U4atac/U6atac.U5 
tri-snRNP (Tarn and Steitz, 1996a), of which the protein composition does not diff er from the 
major-type tri-snRNP (Schneider et al., 2002). 
Overall, the minor spliceosome shares many of the protein factors found in the major 
spliceosome but there are some crucial diff erences (Table 1 and Will et al. (2004)). U11 snRNP 
lacks the U1 snRNP-specifi c proteins U1-70K, U1-A and U1-C, whereas U12 snRNP (within 
the U11/U12 di-snRNP) lacks the SF3a complex. Instead, a unique set of proteins specifi c to the 
minor spliceosome are found from the U11/12 di-snRNP, named 20K, 25K, 31K, 35K, 48K, 59K 
and 65K. Th e 25K, 35K, 48K and 59K proteins are also found in U11 mono-snRNPs (Will et 
al., 2004). Of these proteins, few have been adequately characterized. Th e U11-48K protein has 
been shown to participate in the recognition of the U12-type 5´ ss (Turunen et al., 2008, Tidow 
et al., 2009) but it is also necessary for the stability of the U11/U12 di-snRNP (Turunen et al., 
2008). Based on sequence homology, the U11-35K is thought to be a functional homologue of 
U1-70K (see 1.2.2.2) (Will et al., 1999, Turunen et al., 2008). Th e U11/U12-65K protein binds 
to the U11-59K protein and the U12 snRNA, and in this way, bridges the U11 and U12 snRNPs 
(Benecke et al., 2005). Th e U11-59K protein has been characterized as a DNA-binding protein 
induced during apoptosis (Park et al., 1999). Finally, the U11/U12 di-snRNP appears to contain 
a protein involved in 3´ ss recognition, ZRSR2 (also known Urp). Th is protein was originally 
described to function in 3´ ss recognition for both spliceosomes (Shen et al., 2010). However, 
a recent analysis of the transcriptome derived from cells of patients suff ering from myelodys-
plastic syndrome (MDS) with defects in the ZRSR2 gene suggests that this protein is necessary 
for the 3´ ss recognition of U12-type introns only (Madan et al., 2015).
Table 1. Composition of human spliceosomal snRNPs. Aft er Will et al. (2004) and Will and Lührmann 
(2011).










Sm proteins, SF3b (7 subunits)
Sm proteins, hPrp8, hBrr2, Snu114, 
hPrp6, hPrp6, hPrp28, 52K, 40K, hDib1
Sm proteins, Lsm 2-8, hPrp3, hPrp31, 
hPrp4, CypH, 15.5K
Sm proteins, Lsm 2-8, U5- and U4/U6-
specifi c proteins, hSnu66, hSad1, 27K
Sm proteins, SF3b (7 subunits)
U1-70K, U1-A, U1-C




20K, 25K, 31K, 35K, 48K, 59K, 65K
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1.2.2  Exon and Intron Defi ni? on
In higher eukaryotes, the average exon size is small and introns can be tens of thousands of 
nucleotides long (Sakharkar et al., 2005) and harbor many cryptic splice sites. It is therefore 
challenging to understand how accurate recognition of 5´ and 3´ splice sites across introns can 
take place. A resolution to this is provided by the exon defi nition model that postulates that 
exons, rather than introns are the basic unit of recognition (Fig.3a, and Robberson et al. (1990)). 
Here, individual splice sites are not independently recognized sequences. Instead, spliceosomal 
components that bind the intronic 3´ and 5´ ends interact across the exon to promote spliceosome 
assembly and catalysis (Berget, 1995). Pairing of splice sites is enabled through the binding of the 
small U2AF35 subunit of the U2AF35/65 auxiliary splicing factor at the upstream 3 ´ ss, and the 
U1-70K protein of the U1 snRNP binding at the downstream 5´ ss (De Conti et al., 2013). Th ese 
so-called exon defi nition interactions are oft en facilitated by members of the serine-arginine (SR) 
protein family and mediated through arginine-serine-rich domains (see 1.2.2.2). Th e size of the 
exon can have a detrimental eff ect on the effi  ciency of pairing for exon defi nition: in experiments 
were the exon size was expanded to more than 300 nt, spliceosome formation was inhibited. On 
the other hand, steric hindrance imposes a minimal distance (ca. 50 nt) for exon defi nition to 
occur (Dominski and Kole, 1991, Sterner et al., 1996). 
For short introns, and thus for many introns in lower eukaryotes such as yeast, splice site 
pairing takes place across introns (Talerico and Berget, 1994). As such, during intron defi nition, 
the recognition module operates through pairing adjacent 5´ and 3´ splice sites within one and 
the same intron (Fig. 3b). Experiments in which Drosophila and yeast introns were expanded lead 
to splicing defects such as intron retention (Talerico and Berget, 1994), indicating a preference 
for splice site recognition through intron defi nition in these organisms.
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A special recognition mechanism is required for the defi nition of the fi rst and the last exon of a 
transcript. Th e fi rst exon is defi ned through a mechanism that requires 5´ capping: cell extracts 
where the cap binding protein complex has been depleted show ineffi  cient splicing (Izaurralde 
et al., 1994). For terminal exon defi nition to occur, spliceosomal components must team up 
with cleavage/polyadenylation factors (see 1.3.4, and Berget (1995)). Whatever the model of 
defi nition, there is no diff erence in subsequent spliceosome assembly and for diff erent introns 
on the same pre-mRNA both exon defi nition and intron defi nition can occur. Finally, it is 
important to realize that splice site decision is not solely dependent on the strength of the splice 
site sequences and their respective positioning: there exists a plethora of cis-acting regulatory 
elements that can promote or inhibit spliceosome assembly (Zhang et al., 2008a, De Conti et al., 
2013). 
1.2.2.1  Splicing Enhancers and Splicing Silencers
Especially in the case of U2-type introns from higher eukaryotes, 5´ and 3´ ss sequences can be 
highly degenerate and, as a consequence, splice site-like sequences are fairly common motifs 
in the genome (Sheth et al., 2006). Many of these, however, are never activated for splicing. In 
fact, the mere presence of the splice sites is oft en insuffi  cient to initiate splicing. Information 
over the suitability of splice sites is oft en conveyed by auxiliary cis-acting splicing regulatory 
elements (Zhang et al., 2008a). In the case of splicing enhancers, they promote splicing and they 
can be located both in exons and introns (ESEs and ISEs, respectively). Proteins called splicing 
activators bind these enhancers, and recruit and stabilize components of the spliceosome 
machinery to assist in exon-intron defi nition. On the other hand, splicing silencers, present both 
in exons and introns (ESSs and ISSs, respectively), can attract splicing repressor proteins. In this 
way, activation of cryptic splice sites can be avoided or splicing enhancement is counteracted. 
Taken together, in the presence of both splicing enhancers and silencers, it is oft en the relative 
contributions of splicing activators and repressors that determine whether a given splice site is 
activated (Wang and Burge, 2008). Additional factors however, such as RNA secondary structure, 
have the ability to modulate splice site choice by suppression of pseudo-splice sites, for instance, 
or through stabilization of ESE sequences (Buratti et al., 2004b, Buratti et al., 2007). 
1.2.2.2  Splicing Ac? vators and Repressors
Splicing enhancers recruit trans-acting splicing activators of which the most notable are those 
of the SR protein family (reviewed in Long and Caceres (2009)). SR proteins are typically 
characterized by the presence of 2 motifs: one or two copies of an N-terminal RNA-recognition 
motif (RRM) (Dreyfuss et al., 1988) and a signature C-terminal arginine and serinedipeptide- 
rich domain (RS domain), which enables protein-protein interactions and from which they 
derive their name. SR proteins are recruited to nascent sites of RNA polymerase II (RNAP II) 
transcription and interactions with the C-terminal domain of the largest subunit of RNAP II 
have been documented (Yuryev et al., 1996, Misteli et al., 1997). Th ey typically recognize exonic 
splicing enhancer sequences, through their RRM, and assist, via their RS domain, in exon 
defi nition interactions through recruitment and stabilization of spliceosomal factors (Long 
and Caceres, 2009). More specifi cally, SR proteins have been shown to interact with the SR-like 
U2AF35 protein that binds the 3´ ss, through their respective RS domains (Wu and Maniatis, 
1993). In addition, they can interact with the SR-like U1-70K protein which also contains an RS 
domain (Wu and Maniatis, 1993). Th e U1-70K protein enhances U1 snRNP binding to the 5´ 
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ss, and its RS domain enables a network of cross-exonic protein-protein interactions connecting 
to the upstream 3´ ss (Fig. 3a). Th is method of assisting in exon defi nition interactions is not 
limited to exon bridging in the context of two U2-type introns. Most U12-type introns are 
surrounded by neighboring U2-type introns. Here, SR proteins have also been shown to promote 
binding of the U11 snRNP and U12 snRNP to respectively the 5´ ss and BPS of U12-type introns 
(Hastings and Krainer, 2001). Th e minor spliceosome specifi c U11-35K protein is a likely 
candidate to participate in exon defi nition interactions as its domain structure is similar to that 
of the U1-70K (N-terminal RRM and C-terminal RS domain) with its RS domain thought to 
stimulate protein-protein interactions across exons (Will et al., 1999). Additionally, SR proteins 
can assist in spliceosome recruitment and stabilization, not through promotion of exon defi nition 
interactions, but by forming a network across the intron to bridge U1-70K and U2AF35 via 
their RS domains (Fig. 3b, and Long and Caceres (2009)). Generally, SR proteins are known to 
antagonize the negative eff ects of heterogeneous nuclear RNPs (hnRNPs: see hereinaft er) on 
splicing (Long and Caceres, 2009). 
It is too simplistic to designate SR proteins as splicing activators per se. Th eir function oft en 
depends on the context of the pre-mRNA sequence it binds. For instance, the prototypical SR 
protein SRSF1 (SF2/ASF) can bind an intronic splicing silencer to inhibit adenovirus IIIa pre-
mRNA splicing (Kanopka et al., 1996). In addition, the phosphorylation state of serine residues 
within the RS domain can aff ect the splicing outcome: dephosphorylated SRSF10 has been 
shown to suppress splicing during heat-shock (Shin et al., 2004). Th e phosphorylation state of 
SR proteins has been linked with another important function of SR proteins: the ability to attract 
export factors. For this, certain SR proteins become hypophosporylated upon their contribution 
to splicing which, in turn, increases their affi  nity for the general export receptor NFX1/TAP and 
ultimately leads to the nuclear export of the associated transcripts (Huang et al., 2004). In this 
way, the SR protein phosphorylation state helps the nuclear export machinery to distinguish 
between spliced and unspliced transcripts (Huang and Steitz, 2005). Th e role of SR proteins does 
not stop at the level of splicing activation/repression and mRNA export: the well-studied SRSF2 
protein (SC35), for example, promotes RNAP II elongation in a subset of genes (Lin et al., 2008), 
and some SR proteins have been shown to facilitate recruitment of the U4/U6.U5 tri-snRNP 
(Roscigno and Garcia-Blanco, 1995). Furthermore, the RS domain in SR proteins can act as a 
chaperone of RNA-RNA interactions to enable transitions in the spliceosome (Shen and Green, 
2007). Finally, SR proteins have also been shown to mediate mRNA stability and to regulate 
mRNA translation (reviewed in Huang and Steitz (2005)). 
Whereas SR proteins are generally considered to be activators of splicing, members of the 
hnRNP family are generally thought to act as repressors with a preference for intronic sequences 
(reviewed in Martinez-Contreras et al. (2007)). In this context, they oft en promote exon 
skipping by occluding the binding of spliceosomal components to an overlapping or adjacent 
site. For instance, binding of hnRNP H near a 3´ ss has been shown to inhibit recognition by 
U2AF35 (Jacquenet et al., 2001). When hnRNP H binding sites overlap or are near the 5´ ss, U1 
snRNP binding can be inhibited and exon skipping promoted (Buratti et al., 2004a). HnRNP 
A1, a known antagonist of SR proteins, can prevent binding of SRSF2 at an ESE, through its 
competitive binding at an overlapping ESS (Zahler et al., 2004). Another mode of splicing 
inhibition is through a “looping-out” mechanism in which homo-dimers are formed that bind at 
opposite sides of an exon to promote skipping. Here, the splice sites of two more distal pairs of 
exons are juxtaposed and their splicing stimulated (Martinez-Contreras et al., 2007). However, 
like SR proteins, their function in splicing is not one-dimensional. Indeed, both hnRNP A1 and 
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hnRNP H have been shown to contribute positively to splicing: when there are no exons located 
in between hnRNP binding sites, interactions between bound hnRNPs can loop out intronic 
sequences to assist in intron defi nition (Chabot et al., 2003). Furthermore, binding of hnRNP 
H at a G-tract (sequence with at least 3 consecutive G residues) near a U12-type 5 ´ss has been 
suggested to be required for U11 snRNP binding (McNally et al., 2006). Interestingly, 17 % of 
U12-type introns harbor at least two G-tracts within the fi rst 50 nt following their 5´ ss (McNally 
et al., 2006). Similarly to SR proteins, hnRNPs are involved not only in splicing. Th ey are oft en 
multitaskers participating in processes as various as mRNP export, DNA repair and chromatin 
remodeling (reviewed in Han et al. (2010)). 
Finally, it is noteworthy that splicing activators and repressors do not need to be limited to 
protein components. A snoRNA regulates alternative splicing of serotonin receptor 2C by binding 
to an ESS (Kishore and Stamm, 2006). In addition, there are examples in which metabolites 
directly interact with dynamic RNA structures to aff ect splicing. In an intron in the NMT1 gene 
of the eukaryote Neurospora crassa, binding of thiamine pyrophosphate to a riboswitch alters the 
RNA structure and thereby prevents usage of a splice site by the spliceosomal machinery (Cheah 
et al., 2007). 
1.2.3  Spliceosome Assembly and Catalysis
Interactions of the snRNPs and other spliceosome components with the pre-mRNA are 
established in a step-wise manner. Th e spliceosome is both highly dynamic and fl exible: not only 
must it tediously assemble and disassemble for each splicing event (however, see Nilsen (2002)), 
it undergoes both radical structural and compositional changes at every step of its assembly (Will 
and Lührmann, 2011) and on the basis of biochemical methods, six diff erent complexes can be 
distinguished: the E, A, B, Bact, B*, and C complex (Fig. 4, and Will and Lührmann (2011)). 
Th e catalytic steps of both the U2- and the U12-splicing reactions are identical to those of 
group II introns (Figures 2c and 2d: Cech (1990)). Two transesterifi cation reactions take place: in 
the fi rst reaction, a nucleophilic attack of the 2´ hydroxyl of the bulged branch point adenosine 
to the 5´ ss forms an intron lariat intermediate. Th is is followed by another nucleophilic attack. 
Th is time, the 3´ hydroxyl of the 5´ exon attacks the 3´ ss resulting in the release of the lariat 
intron and the joining of the exons. 
Unlike group II introns, which can function as stand-alone ribozymes, a great number 
of protein factors are involved in intron recognition and removal. At each step of the splicing 
reaction, proofreading takes place in which the same reactive sites in the pre-mRNA are 
recognized both by protein and RNA factors in order to establish accuracy and specifi city. 
Proteins also carry out important functions during spliceosome assembly and structural 
rearrangement steps, and they are crucial for recycling of the snRNPs. Furthermore, proteins 
improve the speed of splicing and guarantee unidirectionality of the splicing reaction. Finally, 
they provide fl exibility of splice site choice and are important mediators of alternative splicing. 
 
1.2.3.1  Major Spliceosome Assembly
Th e assembly of the major spliceosome starts with the formation of the commitment complex (E 
complex): the U1 snRNA base pairs to the 5´ ss (Mount et al., 1983, Zhuang and Weiner, 1986), 
and this interaction is stabilized by the U1-C protein (Heinrichs et al., 1990). In this complex, 
SF1 binds to the BPS, where it defi nes the branch site A (Liu et al., 2001), and the U2AF subunits 
65 and 35 bind to the PPT and 3´ ss, respectively (Zamore and Green, 1989, Berglund et al., 1997, 
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Zorio and Blumenthal, 1999). Formation of the pre-spliceosome or the so-called A complex then 
follows: in a step that requires ATP hydrolysis, U2 snRNP is recruited by U2AF and it displaces 
SF1 at the BPS (Ruskin et al., 1988, Valcarcel et al., 1996). Base pairing interactions between the 
U2 snRNA and BPS cause the branch site adenosine to bulge out (Wu and Manley, 1989, Query 
et al., 1994). 
Figure 4. Spliceosome assembly pathways of the major (left ) and the minor (right) spliceosome. 
Adapted from Turunen et al. (2013a).
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During B complex formation, conformational and compositional changes in the spliceosome 
lead to the introduction of the U4/U6.U5 tri-snRNP (Konarska and Sharp, 1987). Th e pre-
catalytic Bact complex is then formed: extensive remodeling of protein and RNA-RNA interactions 
takes place and the U4 snRNP is expelled, and U1 is replaced by U6, which base-pairs at the 5´ 
ss (Konarska and Sharp, 1987, Kandels-Lewis and Seraphin, 1993). Next, in preparation of the 
fi rst catalytic step of splicing, the 5´ ss and the branch point are brought into close proximity by 
interactions between U2 and U6, forming the catalytic core (Wu and Manley, 1991, Madhani and 
Guthrie, 1992). Th e U5 snRNP further assists in exon alignment through contacts at the exonic 
sides of the 5´ ss and the 3´ ss (Newman and Norman, 1992, Cortes et al., 1993, Sontheimer and 
Steitz, 1993). Subsequent catalytic activation by the DEAH-box RNA helicase Prp2 generates the 
activated complex B* and the fi rst step of splicing is catalyzed (Gencheva et al., 2010, Will and 
Lührmann, 2011). 
Aft er the fi rst step of splicing, SF3a and SF3b dissociate and other factors enter the 
spliceosome and facilitate the conformational changes required for complex C formation 
(Bessonov et al., 2008). Th e second catalytic step takes place leading to exon-exon ligation and 
release of the lariat. Finally, the spliceosome disassembles and the released snRNPs can take part 
in additional rounds of splicing (Will and Lührmann, 2011).  
1.2.3.2  Minor Spliceosome Assembly  
Overall, the assembly of the minor spliceosome resembles that of the major spliceosome (Patel 
and Steitz, 2003). However, due to the nature of the U11/U12 di-snRNP and the distinct protein 
repertoire of the minor spliceosome, initial recognition diff ers between the two systems. For the 
minor spliceosome, the fi rst stage of assembly, the formation of the A complex, is characterized by 
the cooperative and simultaneous binding of the U12-type 5´ ss by the U11 snRNA, and the BPS 
by the U12 snRNA (Hall and Padgett, 1996, Kolossova and Padgett, 1997, Frilander and Steitz, 
1999). Here, base-pairing of U11 with the U12-type 5´ ss is limited to 6 nucleotides (positions +4 
to +9) but the U11-48K assists through its recognition of the fi rst three nucleotides of the U12-
type intron (Turunen et al., 2008). Th e BPS of U12-type introns is very constrained and the 3´ 
end of the intron lacks a clear PPT, suggesting that recognition of the BPS by the U12 snRNP is 
more reliant on RNA-RNA interactions (Brock et al., 2008). Upon base pairing of U12 snRNA 
with the BPS, bulging of the branch point adenosine is achieved (Tarn and Steitz, 1996b). In 
addition, formation of the A complex requires the binding of Urp/ZRSR2, a U2AF35-like protein 
factor that recognizes the 3´ ss (Shen et al., 2010). Th e B complex of the minor spliceosome 
is characterized by the entry of the U4atac/U6atac.U5 tri-snRNP: U11 and U4atac dissociate, 
followed by base pairing of U6atac with U12 forming the catalytic core of the minor spliceosome 
(Tarn and Steitz, 1996a, Yu and Steitz, 1997, Incorvaia and Padgett, 1998, Frilander and Steitz, 
2001). Similarly as in the minor spliceosome, this interaction, through additional base pairing of 
U6atac with the 5´ ss, brings the 5´ ss and BPS in close proximity and U5 snRNP aligns the exons 
in a similar way as during major spliceosome assembly. Th e two transesterifi cation reactions 
then take place and ultimately result in exon-exon ligation and lariat intron release. Disassembly 
and recycling of the snRNPs is thought to be similar to that of the major spliceosome (Damianov 
et al., 2004). 
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1.2.4  Alterna? ve Splicing 
During constitutive splicing, splicing events that take place in the majority of all cell types during 
various developmental stages generate the primary transcript from a given gene. However, for 
almost all genes in higher eukaryotes (at least 95 %: Pan et al. (2008)), there is a fl exibility of splice 
site choice, and alternative splicing can generate multiple transcripts from one and the same gene. 
In this way, the number of diff erent genomic transcripts and the protein repertoire of the cell are 
greatly expanded (Nilsen and Graveley, 2010). In unicellular cells, however, alternative splicing 
is absent or very rare, and here, one gene provides one protein product (Ast, 2004). A number of 
diff erent splicing mechanisms can be employed by alternative splicing (Fig. 5). Th ese include, but 
are not limited to: exon skipping or inclusion, alternative 5´ ss activation with preservation of the 
original 3´ ss, alternative 3´ ss activation, intron retention where splicing has not taken place at 
all, and mutual exon exclusion where either one of two exons is included (Fig. 5, and Nilsen and 
Graveley (2010)). Which splicing event takes place is oft en dictated by the relative contributions 
and activity of the diff erent splicing activators and repressors in a given tissue or during a given 
developmental stage (see 1.2.2.2). 
Figure 5. Mechanisms of alternative splicing. Adapted from (Ast, 2004).
Apart from the activity and concentration of splicing activators and repressors that bind 
enhancers or silencers, the elongation rate of the RNAP II can also have a profound eff ect on 
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which transcriptional elongation can aff ect the timing at which splice sites are available to the 
spliceosome. Here, kinetic competition can have a signifi cant impact on alternative splicing 
decisions and slow elongation can favor the activation of an intrinsically weaker 3´ ss competing 
with a stronger but more downstream located 3´ ss (see 1.3.1, and Kornblihtt et al. (2004), 
Bentley (2014)).
Finally, care must be taken that alternative splicing is well regulated: many genetic disorders 
result from abnormal splicing variants (Matlin et al., 2005, Tazi et al., 2009), and miss-regulated 
alternative splicing is also thought to contribute to the development of cancer (Skotheim and 
Nees, 2007, Fackenthal and Godley, 2008).
1.2.4.1  Regulatory Role of Alterna? ve Splicing  
Th e functional consequences of alternative splicing can be quite diverse. On one hand, it increases 
the proteome diversity and has the ability to change enzymatic properties, ligand specifi city or 
localization of the protein product (Kelemen et al., 2013). Alternative splicing can also have a 
profound eff ect on the localization, the stability and the abundance of the mRNA itself (reviewed 
in Kelemen et al. (2013)). For example, regulated unproductive splicing and translation (RUST) 
is a mechanism in which binding of cis-elements located on the mRNA dictate an alternative 
splicing event, so that the coding frame is disrupted and a premature termination codon (PTC) 
is introduced (Lewis et al., 2003). Th is will lead to degradation of the message by virtue of the 
NMD pathway (see 1.3.3). RUST is a regulated mechanism: it is triggered in certain cell types 
during specifi c conditions, and the cis-elements are oft en highly conserved revealing functional 
importance. Indeed, it has been shown that many splicing factors employ RUST to auto-regulate 
expression of their own gene or cross-regulate expression of other splicing factors (Lareau and 
Brenner, 2015). Diff erent regions in the 3´ UTR of the SRSF1 gene are responsible for its auto-
regulation, which involves multiple layers of post-transcriptional and translational control (Sun 
et al., 2010). Increased levels of SRSF2 (SC35) promote alternative splicing in the 3´ UTR of its 
own gene, leading to transcripts that are degraded by NMD (Sureau et al., 2001). SRSF3 has 
been shown to be a master regulator of the SR protein family by auto-regulating its own gene, 
and through a cross-regulatory mechanism in which it directs alternative splicing of SRSF2, 
SRSF3, SRSF5 and SRSF7 to include PTC-containing exons (Änkö et al., 2012). A combination of 
auto- and cross-regulation also occurs for the splicing repressor PTB and its neuronal expressed 
paralogue nPTB (also known as PTBP1 and PTBP2, respectively). Here, PTB auto-regulates 
expression of its own gene and cross-regulates nPTB expression, both via non-productive 
alternative splicing (Spellman et al., 2007).  
1.2.4.2  Alterna? ve Splicing of U12-type Introns
Due to the constrained splice site sequences and the relative scarcity of these sequences in the 
genome, alternative splicing is rare for U12-type introns (Levine and Durbin, 2001, Chang et 
al., 2007). Th ere is evidence that minor splicing is responsive to exonic purine rich splicing 
enhancers and that exon skipping or inclusion, and alternative 3´ ss usage is possible in vivo 
for neighboring U12-type introns (Dietrich et al., 2001). For the human JNK2 gene, regulated 
alternative splicing exists in which mutually exclusive exon selection is driven by the activation of 
either one of two U12-type 5´ splice sites and a downstream U12-type 3´ ss (Chang et al., 2007). 
Such conformations are rare: U12-type introns are in reality exclusively surrounded by their 
major-type counterparts (with the exception of the AOX1 and XDH genes: Lin et al. (2010)), and 
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adjacent alternative U12-type 5´ or 3´ splice sites are oft en absent. Other studied U12-alternative 
splicing events constitute a competition where either U2- type or U12-type splicing takes place. 
In the Prospero gene of Drosophila melanogaster, a U2-type intron is embedded within a U12-
type intron, and splicing through either the minor or the major spliceosome is regulated and 
changes the homeo-domain of the protein (Borah et al., 2009). A reverse case can be found in 
the Drosophila Urp gene, where a U12-type intron is embedded within a U2-type intron and, 
interestingly, processing of the U12-type intron is predicted to lead to degradation by NMD 
(Lin et al., 2010). Notwithstanding the rarity of U12-type alternative splicing, the development 
of large-scale sequencing methods is expected to produce further examples and to enhance our 
understanding on the regulation of such splicing.   
1.3  Splicing and other pre-mRNA Processes
Virtually all machineries that carry out any of the steps in pre-mRNA processing are closely 
interconnected and oft en share components. Th is is no diff erent for the spliceosome and its 
components. Splicing factors couple extensively with many other pre-mRNA processing factors 
and here, the interdependence between splicing and transcription, as well as other processes will 
be explored.
 
1.3.1  The Timing of Splicing
It is well established that most spliceosomes assemble and catalyze intron removal while the 
RNAP II still is transcribing the pre-mRNA in the nucleus (Brugiolo et al., 2013). Using electron 
micrographs, co-transcriptional splicing was visualized for transcription units of Drosophila 
melanogaster where transcripts were observed which displayed loop formation and removal 
before termination of transcription (Beyer and Osheim, 1988). Total RNA-seq data show 
underrepresentation of intronic counts near the 3´ ends of the introns, indicating that introns are 
removed and degraded soon aft er 3´ ss transcription (Ameur et al., 2011). Furthermore, many 
spliceosomal factors, including SR proteins and U2AF65, are known to associate with RNAP II 
through the carboxy-terminal domain (CTD) of its largest subunit (Misteli and Spector, 1999, 
David et al., 2011), a landing pad for many processing factors. In addition, U1 snRNP has been 
shown to be recruited to splicing competent as well as splicing defi cient transcription units 
(Spiluttini et al., 2010). 
Th e rate of RNAP II transcription elongation can aff ect alternative splicing in the so-called 
kinetic coupling model (Kornblihtt, 2005). Th e average RNAP II transcription elongation rate 
has been estimated to range from 1.9 kb min-1 to 4.3 kb min-1 (Boireau et al., 2007, Darzacq et al., 
2007). Co-transcriptional splicing of U2-type introns has been measured to require 5-10 minutes 
but minor splicing is somewhat slower (ca. 10 minutes: Singh and Padgett (2009)). In another 
study, MS2 labeling of introns combined with live-cell confocal microscopy, allowing high-
resolution detection of individual pre-mRNAs, revealed a much faster time for splicing. Here, the 
mean intron lifetime was measured to be 30-40 seconds (Martin et al., 2013). Kinetic coupling 
allows coordination of transcription and splicing, and thus, the transcription elongation rate 
can determine a window of opportunity for alternative processing. For example, fast elongation 
rates can promote exon skipping, whereas slow elongation rates oft en promote inclusion of exons 
with suboptimal splice sites (Kornblihtt et al., 2004, Bentley, 2014). Th is coordination can be 
regulated and mechanisms exist to alter RNAP II elongation rate: in yeast, the polymerase pauses 
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downstream at introns to accommodate co-transcriptional splicing, and pausing occurs at the 
beginning of mammalian exons perhaps because of high nucleosome density (Schwartz et al., 
2009, Alexander et al., 2010, Kwak et al., 2013). 
In some cases however, splicing and transcription are uncoupled. Using single molecular 
fl uorescence in situ hybridization (FISH), post-transcriptional splicing has been observed with 
introns associated with skipped exons in the SXl and PTB2 genes (Vargas et al., 2011). In addition, 
analysis of intron presence in nascent versus released Drosophila BR1 pre-mRNA demonstrated 
that, while most introns are removed in a co-transcriptional manner, introns close to the 
polyadenylation signal can be spliced post-transcriptionally (Bauren and Wieslander, 1994). 
Indeed, the degree of co-transcriptional splicing seems to be dependent on intron positioning: 
upstream introns are spliced more co-transcriptionally than downstream introns (Khodor et al., 
2012). Furthermore, the rate at which introns are removed can have an eff ect. Th e slower the 
intron removal, the more likely splicing will occur post-transcriptionally (Bentley, 2014). Even 
though there are some reports that suggest that post-transcriptional splicing serves to quickly 
release transcripts from the transcription site to prevent binding of constitutive splicing factors 
(Vargas et al., 2011), the functional consequences as to whether an intron is co-transcriptionally 
or post-transcriptionally spliced are currently unclear (Bentley, 2014).
Overall, the co-transcriptional nature of splicing has many benefi cial eff ects: 
co-transcriptional splicing is a fundamental requirement for many alternative splicing events 
(see above, and Schor et al. (2013)). Furthermore, it enhances the effi  ciency and the accuracy of 
pre-mRNA maturation, allows the communication of splicing factors with chromatin and the 
interaction of the U1 snRNP with 3´ end processing factors (Bentley, 2014).    
    
1.3.2  Splicing and Nuclear Export
Correct processing of an mRNA is a requirement for nuclear export. Failure to do so will lead 
to retention and subsequent degradation of the mRNA by the nuclear surveillance machinery 
(Schmid and Jensen, 2010). Splicing promotes nuclear export by depositing protein factors at 
the site of exon fusion, the so-called exon-junction complex (EJC). Th e hetero-tetramer core of 
the EJC consists of eIF4AIII, Y14, Magoh, and MLN51 (Tange et al., 2005) which are deposited 
ca. 20–24 nucleotides upstream of exon–exon junctions, regardless whether U2- or U12-type 
splicing took place (Le Hir et al., 2000, Le Hir et al., 2001, Hirose et al., 2004). Formation of the 
EJC is suggested to be initiated through the EJC core protein Y14, which associates both with 
intron pre-mRNA and U snRNPs with the highest affi  nity for the U2 snRNP (Shiimori et al., 
2013). Th e EJC core proteins serve as a binding platform allowing the transient association of 
other EJC factors, such as the UAP56 and Aly proteins (Cullen, 2003, Tange et al., 2005). Th ese 
proteins are also part of the transcription-export (TREX) complex which is recruited during 
splicing (Strasser et al., 2002, Masuda et al., 2005). Both UAP56 and Aly are critical components 
for the binding of the NXF1/TAP heterodimer, a known export receptor (Reed and Hurt, 2002). 
Hypo-phosphorylated SR proteins are an additional mark for nuclear export. Th ey serve as a sign 
that splicing has taken place, and are known to interact with the NXF1/TAP exporter (Huang 
et al., 2004). More recently, an additional mechanism by which splicing aff ects mRNA export 
has been described for the human β-globin mRNA. Here, the splicing machinery, rather than 
recruiting export factors, operates through the removal of nuclear retention signals from the 
intron (Akef et al., 2015). 
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1.3.3  Splicing and Quality Control: Nonsense Mediated Decay
Prevention of nuclear export in the case of failure to splice or incorrect splicing is an important 
quality control system because premature export can give rise to potentially toxic protein 
products. Th e EJC off ers an additional layer of quality control by degrading potentially lethal 
mRNAs in the cytoplasm through the NMD pathway (Lykke-Andersen et al., 2001). Typically, 
transcripts that contain a premature termination codon (PTC) are targeted by a translation-
dependent mechanism. Such a PTC can be introduced through mutation, intron retention, or 
splicing errors. Following nuclear export, an initial round of translation takes place, and the 
ribosome dislodges EJCs from the mRNA. Recognition of the stop codon leads, through the 
action of eRF1 and eRF2, to the recruitment of Upf1 (Kashima et al., 2006). Upf1 can then sense 
downstream splicing events through its interaction with two components that associate with the 
EJC: Upf2 and Upf3 but only if the EJC is located suffi  ciently far downstream (ca. 50-55 nt) (Nagy 
and Maquat, 1998). However, some mRNAs with extended 3´ UTRs are also NMD substrates, 
and it has been proposed that the most crucial determinant for NMD substrate recognition is 
the distance between the PTC and the 3´ end, more specifi cally the cytoplasmic poly(A)-binding 
protein 1 (PABPC1) (Muhlrad and Parker, 1999, Amrani et al., 2004, Behm-Ansmant et al., 2007, 
Silva et al., 2008, Singh et al., 2008, Eberle et al., 2008). In either way, NMD substrates are then 
decapped and degraded by both exonucleases and endonucleases (Rebbapragada and Lykke-
Andersen, 2009).
Although the main function of NMD seems to be the removal of deleterious mRNAs 
generated through unintentional processing errors, it can also perform a function in a regulatory 
mechanism called regulated unproductive splicing and translation (RUST). Here, oft en a 
so-called “poison exon” is included through alternative splicing and the destruction of the 
mRNA is part of a regulatory pathway (see 1.2.4.1, and Lewis et al. (2003)).                       
           
1.3.4  Splicing and 3´ End Processing
Cleavage/polyadenylation (CP) constitutes a key event during pre-mRNA processing. It enables 
nuclear export and ensures stability and proper translation of the mRNA (Wickens et al., 1997). 
In essence, it is a two-step process: an endonucleolytic cleavage reaction followed by the addition 
of the poly(A) tail by the polyadenylate polymerase (PAP). Nearly all polyadenylated mRNAs 
from animal cells contain the consensus poly(A) signal “AAUAAA” sequence, or a close variant 
thereof (Wahle and Kuhn, 1997). However, due to redundancy and the low complexity of the 
signal, additional elements are required to prevent premature 3´ end processing. It is now realized 
that the unit of recognition for 3´ end processing oft en includes an upstream 3´ ss (Martinson, 
2011). Functional coupling between CP and splicing has already been demonstrated for a long 
time (Niwa et al., 1990, Niwa and Berget, 1991). Since then, factors have been identifi ed that 
participate in the coupling (Gunderson et al., 1997, Vagner et al., 2000b, McCracken et al., 2002, 
Millevoi et al., 2006, Kyburz et al., 2006). Th e interconnectivity between splicing and CP ensures 
mutual stimulation, defi nes the terminal exon, and furthermore, promotes transcriptional 
termination (Dye and Proudfoot, 1999). 
While the presence of an upstream 3´ ss can activate a poly(A) site, a 5´ ss oft en has an 
inhibitory eff ect on CP, mediated by interactions of the U1 snRNP with components of the 
poly(A) machinery. Various mechanisms, either indirect or involving interactions with the CP 
machinery, have been described through which the U1 snRNP can execute a suppressive eff ect 
on CP. In the U1A gene, a conserved U1 site in the 3´ UTR inhibits polyadenylation and forms 
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part of an auto-regulatory negative feedback loop (Boelens et al., 1993, Guan et al., 2007). In 
bovine papillomavirus (BPV) late transcripts, a direct interaction between the U1-70K protein 
and PAP specifi cally inhibits polyadenylation (Gunderson et al., 1998). For this, the U1 site is 
located upstream of the poly(A) site. In the 5´ long terminal repeat (LTR) of the HIV-1 provirus, 
however, a downstream U1 site leads to inhibition of the cleavage step (Ashe et al., 1997). Here, 
the interaction is thought to be with a cleavage factor, rather than with PAP (Vagner et al., 2000a), 
and again, the U1-70K protein is likely to be involved (Ashe et al., 2000). Th ese two types of 
inhibition serve diff erent purposes: for BPV, the production of cleaved but non-polyadenylated 
mRNAs that are presumably unstable, and in the case of HIV-1, the regulation of transcriptional 
read-through to generate full-length viral pre-mRNA to be packaged into viral particles. 
Interestingly, for both mechanisms of CP inhibition, the U1 site exhibits a high degree of affi  nity 
for the U1 snRNA, which is a prerequisite at least when the U1 site is located upstream of the 
poly(A) site (Abad et al., 2008). In a method to inhibit gene expression, termed U1 interference 
(U1i), U1 snRNP has been shown to exhibit long-distance (> 1000 nt) inhibition of CP. Th is 
inhibition is thought to be due to a disruption of terminal exon defi nition, rather than to result 
from an interaction with the U1-70K protein (Fortes et al., 2003). In the IgM heavy chain gene, 
again, no direct interaction between U1 snRNP and the CP machinery takes place. Instead, a 
competition exists between an intronic poly(A) site and an upstream, suboptimal 5´ ss (Peterson, 
2011). Here, a model has been suggested where a race to form either a cross-intron A complex 
with a downstream 3´ ss, or the 3´ terminal A-like complex will determine the outcome of the 
competition. Factors that delay (or hasten) this event for splicing promote (or suppress) CP, and 
vice versa (Martinson, 2011). On a more global scale, a role for the U1 snRNP has been shown in 
protecting the whole transcriptome from premature CP events (Kaida et al., 2010). 
1.4  The Minor Spliceosome: Signifi cance 
Several U12-type introns are extraordinarily conserved, the most notable example being the 
second intron in the gene encoding the sodium channel α-subunit present both in humans and 
jellyfi sh (Wu and Krainer, 1999), organisms that diverged 600-800 million years ago (Spaff ord 
et al., 1998). Additionally, U2-type intron positions are more conserved than U2-type intron 
positions between Arabidopsis thaliana and human (Basu et al., 2008a). It appears that there is a 
selection pressure to maintain U12-type introns in certain genes, perhaps because their presence 
is important for the expression of the genes that harbor them. Th ere is no clear enrichment of 
U12-type introns in genes related to specifi c molecular functions or biologically processes. U12-
type introns seem to be mainly present in genes involved in more broadly defi ned ´information 
processing´ functions, such as DNA replication and repair, transcription, RNA processing, and 
translation. In addition, they can also be found in genes related to cytoskeletal organization, 
vesicular transport, and voltage-gated ion channel activity (Burge et al., 1998, Wu and Krainer, 
1999). In this chapter, the possible reasons for retaining two diff erent spliceosomes, which 
seemingly carry out the same task, and some recently described diseases associated with defects 
in minor splicing will be discussed. 
1.4.1  Func? on and Regula? on of the Minor Spliceosome
An important insight into the role of the U12-type intron came from studies in which the 
abundance of unspliced U12-introns was compared to that of U2-type introns: consistently 
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higher levels of unspliced U12-type introns were detected compared to the U2-type introns 
(Patel et al., 2002). When measuring fl uorescence levels from reporter constructs, it was 
observed that reporters with a U2-type intron produced 6-8 fold more of the fl uorescent protein 
compared to when a U12-intron was present in the exact same position (Patel et al., 2002). It was 
concluded that the removal of U12-type introns could be a rate-limiting step for the expression 
levels of genes that harbor them and therefore, U12-type introns act as some kind of post-
transcriptional bottleneck. Reduced levels for U12-type intron splicing have been confi rmed in 
other in vivo studies as well (Santoro et al., 1994, Pessa et al., 2006). Furthermore, a knock-down 
of components of the nuclear exosome leads to the upregulation of the nuclear retention of U12-
type introns but not of U2-type introns (Niemelä et al., 2014). Th ese data support a model where 
the delay in processing for transcripts with U12-type introns make them more likely targets for 
the nuclear exosome, off ering a means to control gene expression.  
Th e retention of U12-type introns could be explained by their slower splicing. Earlier in 
vitro studies have shown that the removal of U12-type introns is dramatically slower (Tarn and 
Steitz, 1996b, Wu and Krainer, 1996) and in vivo measurement of the splicing kinetics estimate 
minor splicing to be on average two times slower (Singh and Padgett, 2009). An analysis of the 
decay rates of U12-type introns led to the observation that U12-introns are remarkably stable 
aft er nuclear exosome knock-down (Niemelä et al., 2014) and an alternative hypothesis was 
proposed to explain the perceived retention of U12-type introns. Whereas some U12-type 
intron containing transcripts are spliced rather effi  ciently, a subpopulation fails to splice entirely 
(Niemelä and Frilander, 2014). Perhaps, one of the components of the minor spliceosome is 
limiting the formation of a catalytically active spliceosome combined with a higher dependency 
for the minor spliceosome on co-transcriptional splicing. 
Regardless of whether minor splicing is either slow or ineffi  cient, what could be the 
underlying mechanistic reason for the higher levels of unspliced U12-type introns? Th e snRNPs 
of the minor spliceosome are ca. 100-fold less abundant than those of the major spliceosome in 
mammalian cell nuclei and nuclear extracts (Montzka and Steitz, 1988, Tarn and Steitz, 1996a), 
off ering a possible explanation. However, a 10-fold reduction of U4atac, the least abundant of the 
U12-type snRNAs, did not seem to have any signifi cant impact on the effi  ciency of endogenous 
U12-type splicing (Pessa et al., 2006). On the other hand, U6atac is relatively unstable (half-life < 
2hr), and has been shown to be stabilized by the cell-stress activated kinase p38MAPK, resulting 
in the enhanced splicing of U12-type introns and increased expression of their associated mRNAs 
(Younis et al., 2013). Additionally, a protein factor associated with the minor spliceosome could 
be in rate-limiting concentrations. Perhaps, its expression or activity could vary in diff erent cell 
types or during diff erent developmental stages, enabling regulation of the activity of the minor 
spliceosome. 
It has been argued that the recognition step of the U12-type introns is not crucial for the 
perceived higher U12-type intron retention: both a disease that hampers U12-type intron 
recognition (Argente et al., 2014) and knock-down of the U11-48K protein, which recognizes 
the U12-type 5´ ss (Turunen et al., 2008), lead to the activation of cryptic U2-type 5´ splice sites 
(Niemelä and Frilander, 2014). Th us, when U12-type intron recognition is impaired, U2-type 
splicing typically takes over: the crucial steps that lead to slow or ineffi  cient splicing are more 
likely to take place during minor spliceosome assembly or during the catalytic steps.        
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1.4.2  Minor Spliceosome and Disease
A number of pathological conditions have been found resulting either from mutations in the 
splicing signals of U12-type introns, mutations that aff ect minor snRNP processing or mutations 
directly aff ecting a protein component of the minor spliceosome. In Peutz-Jeghers syndrome 
and spondyloepiphyseal dysplasia tarda (SEDT), the U12-type 5´ ss in the LKB1 or SEDL 
genes, respectively, are mutated and the disease phenotype is most likely caused by the reduced 
availability of the corresponding proteins (Hastings et al., 2005). Homozygous inactivation of 
the survival motor neuron 1 (SMN1) gene leads to spinal muscular atrophy (SMA) (Lefebvre et 
al., 1995). Th e SMN protein forms a macromolecular complex involved in the biogenesis of the 
snRNPs of the Sm class (Pellizzoni, 2007, Neuenkirchen et al., 2008). Defects in minor splicing 
are thought to contribute to the disease phenotype because SMA reduces the levels of minor 
snRNPs to a greater extent than those of the major snRNPs (Gabanella et al., 2007, Zhang et 
al., 2008b). Indeed, in Drosophila melanogaster, SMN defi ciency decreases the expression of a 
U12-type intron containing gene required for proper motor circuit function (Lotti et al., 2012). 
Mutations in the ZRSR2 gene, encoding for a splicing factor recognizing the 3´ splice sites of 
both U2- and U12-type introns, can lead to myelodysplastic syndrome (MDS) (Yoshida et al., 
2011). Here, aberrant retention of U12-type introns is prevalent, whereas U2-type introns remain 
largely unaff ected (Madan et al., 2015).  
In recent years, several pathological conditions have been described resulting from 
mutations in core components (snRNA and protein) of the minor spliceosome. Mutations in 
the U11/U12-65K gene are associated with a case of isolated familial growth hormone defi ciency 
(IGHD1) and pituitary hypoplasia (Argente et al., 2014). In microcephalic osteodysplastic 
primordial dwarfi sm type I (MOPD1, also known as Taybi-Linder Syndrome), the clinical 
phenotype is much more severe: patients suff er several developmental defects and typically 
die within three years (Nagy et al., 2012). Here, a mutation is located within a phylogenetically 
conserved stem-loop structure in the U4atac snRNA (He et al., 2011, Edery et al., 2011, Pessa 
and Frilander, 2011). Th is is believed to disrupt base pairing with U6atac and suppress binding 
of the spliceososomal protein 15.5 K. Th is protein is presumably required for the association of 
the U5 snRNP to form the U4atac/U6atac.U5 tri-snRNP (Nottrott et al., 2002, Makarova et al., 
2002). A diff erent set of compound heterozygous mutations in the RNU4ATAC gene, encoding 
the U4atac snRNA, cause Roifman syndrome (Merico et al., 2015). Here, one mutation aff ects 
the conserved stem-loop structure which is also mutated in MOPD1, and another mutation 
aff ects another highly conserved element, stem II. In Roifman syndrome, the disease phenotype 
is much milder, leading to non-fatal retinal dystrophy, poor pre- and postnatal growth, cognitive 
delay and facial dysmorphism. It is currently unclear how the minor splicing defects lead to the 
specifi c pathologies seen in these conditions and why such tissue specifi city is observed. Finally, 
it is possible that there are other diseases linked to mutations in the other minor spliceosomal 
snRNAs: future genome sequencing would help reveal these cases.
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2.  AIMS OF THE STUDY
Although recent fi ndings have shed some lights on the minor spliceosome and its workings, its 
exact role and regulation are largely unknown. Th is thesis aims to characterize in more detail the 
regulation of the minor spliceosome. More specifi cally: (1) to identify and characterize the role 
of an ultraconserved sequence element, containing a duplication of a U12-type 5´ ss, found in 
two genes coding for proteins specifi c to the minor spliceosome. We hypothesized that a negative 
feedback loop regulatory mechanism would act through non-productive alternative splicing 
and subsequent downregulation of the expression of the genes which harbor these elements. 
Aft er characterization of this regulatory mechanism, a study was initiated (2) to gain detailed 
molecular insights into the mechanism by which this element downregulates the translational-
competent mRNA levels of the U11/U12-65K gene and, in addition, regulates minor splicing 
in general. A further study was undertaken (3) to investigate the role of the U11-35K protein, a 
protein associated with the minor spliceosome, and its ability to activate the splice site located 
upstream from the conserved element, as well as genuine U12-type 5´ splice sites. Additionally, 
in order to get mechanistic insights into the binding properties of the element, the requirements 
for the distance between the two 5´ ss-like motifs within the element, and for the distance of the 
element to the activated splice site were investigated.
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3.  MATERIALS AND METHODS
Methods used in this study are listed in table 2. For a detailed description of methods, see the 
original publications.
Table 2. Overview of methods used in this study.
Method Publica? on
Cell frac? ona? on
Cell lines and culture
Fluorescence in situ hybridiza? on
Immunofl uorescence
Immunoprecipita? on
In vitro splicing and spliceosome assembly assays
In vivo splicing reporter assays
Luciferase expression assays
Northern blo?  ng
Protein overexpression in mammals


































4.  RESULTS AND DISCUSSION
4.1  Ultraconserved non-coding regions in minor spliceosome-
associated genes are linked to alterna? ve splicing (I)
Th ere are seven proteins uniquely associated with the minor spliceosome, and it has been 
hypothesized that their expression might be linked to the activity of the minor spliceosome (Will 
et al., 2004). Th e U11-48K, which assists in the recognition of the U12-type 5´ ss (Turunen et 
al., 2008), is a potential candidate regulator, and the serendipitous fi nding of an ultraconserved 
region in its gene provided an interesting starting point to investigate a potential regulatory 
mechanism. Th e ultraconserved region in the 48K gene is located in the intron between exons 
4 and 5 (Fig. 6a) and encompasses ca. 110 nt in the 25 mammalian species examined. Here, 
ultraconserved regions are defi ned as sequences that are over 100 nt long and that have > 90 % 
sequence similarity in mammals. 
Th e presence of ultraconserved regions in this gene does not come as a surprise per se. In fact, 
the presence of ultraconserved sequences in non-coding regions is a widespread phenomenon in 
eukaryotes and, furthermore, has been shown to be particularly associated with RNA binding and 
processing factors (Bejerano et al., 2004). However, most interestingly, within the ultraconserved 
region in the U11-48K gene, a duplication of the consensus U12-type 5´ splice site separated 
by a 6 nt spacer, was found. From a further comparison of the 48K genes in fi sh and insects, 
we identifi ed a “core” conserved region with very divergent fl anking and interspersing DNA 
sequences. Th is core consists of a PPT and adjacent U2-type 3´ ss, combined with the ca. 40-60 
nt downstream located duplicated U12-type 5´ ss. Th is prompted a bioinformatics search to look 
for similar sequence elements in the human genome. Several thousands were found but only 
one single element showed ultraconservation in mammals, located in the 3´ UTR of the 65K 
gene (also known as RNPC3)(Fig. 6b), coding for a protein with a role in U11/U12 di-snRNP 
formation and intron bridging (Benecke et al., 2005). Sequence similarity of the region in the 
65K 3´ UTR was still very high when comparing mammals with reptiles and birds. However, the 
core structure was the only recognizable conservation we observed from a further comparison 
with fi shes. Ultraconservation of elements covering hundreds of nucleotides in mammals and 
birds and a reduction to a shorter core sequence in fi sh is a common theme (Bejerano et al., 2004, 
Sabarinadh et al., 2004). Many ultraconserved elements are thought to be chordate innovations 
rapidly evolving at fi rst and then frozen in birds and mammals (Bejerano et al., 2004). Our 
discovery of a core sequence (PPT + 3´ ss + duplicated U12-type 5´ ss) in the 3´ UTR of the 48K 
gene of plants (Fig. 6c), however, indicates that such a sequence was presumably present already 
in the common ancestor of plants and animals, and that the mechanism by which it operates is 
under enormous evolutionary selection pressure.         
Based on EST data, the conserved regions in both 48K and 65K genes were found to be 
associated with alternative splicing events. However, there was no evidence that the U12-type 
5´ splice sites were used for splicing. In the human 48K, alternative splicing leads to either 
inclusion of an 8 nt mini-exon (termed exon 4i), or inactivation of the 3´ ss downstream of exon 
4i to generate an 1852 nt long exon. Similarly, in 65K, alternative 3´ ss activation leads to the 
production of an isoform with an 1839 nt elongated 3´ UTR. We confi rmed the presence of the 
48K mini-exon transcript and the long 65K isoform in vivo in HEK293 cells (I, Fig. 4C and D). 




Figure 6. Conserved sequence elements and alternative splicing in animal (A) and plant (C) 48K 
genes, and in the animal 65K gene (B). Th e upper part depicts genomic organization and splice 
variants: blue boxes depict protein-coding exons, the 3´ UTR is in yellow, and the thin horizontal lines 
are introns. Th e middle part is a phylogenetic conservation plot and the blow-up below shows residue-
level conservation of the sequence elements.
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Arabidopsis thaliana and Populus trichocarpa: alternative 3´ ss usage and intron retention (I, Fig. 
S1D).
Th e most obvious hypothesis is that the duplicated U12-type 5´ ss acts as a splicing enhancer 
to activate the upstream 3´ ss, either directly or indirectly. Excitingly, given its affi  nity for the 
U12-type 5´ ss, this could signify a novel role for the U11 snRNP as an activator of alternative 
splicing without direct participation in actual splicing.
4.2  U11 binds the conserved enhancer and ac? vates 
alterna? ve splicing through exon defi ni? on interac? ons 
mediated by the U11-35K protein (I and II)
To address the role of the duplicated 5´ ss sequences, I transfected antisense morpholino oligos 
targeting the duplicated U12-type 5´ ss in the human 65K gene, and observed complete loss 
of alternative splicing and a shift  to the canonical isoform with a short 3´ UTR (I, Fig. 4D). 
For technical reasons, it was not possible to target the 48K element with morpholino oligos. 
Th erefore, we used 2´ O-Methyl oligos, which resulted in a loss of 48K exon 4i inclusion (I, 
Fig. 4C). To further pinpoint the role of the U11 snRNP, I mutated nucleotides (AG5/6TC) that 
are absolutely required for U11 snRNP binding (Kolossova and Padgett, 1997) in either one or 
both of the U12-type 5´ splice sites, and observed complete loss of alternative splicing in each 
case. Such a loss-of-function phenotype provides a strong support for the essential role of the 
5´ ss elements, but does not prove causality. Consequently, I then attempted a genetic rescue 
by co-transfection of a U11 snRNA with compensatory mutations that are expected to restore 
Watson-Crick base pairing. Such an elegant strategy has been previously employed to reveal the 
role of U1 and U11 snRNAs in U2-type and U12-type 5´ ss recognition respectively (Zhuang and 
Weiner, 1986, Seraphin et al., 1988, Kolossova and Padgett, 1997), and has the capacity to reveal 
a direct causal relationship between U11 snRNP binding and alternative splicing. Gratifyingly, 
upon co-transfection, alternative splicing was restored (I, Fig. 4F) and the sequence element 
with U12 5´ ss repeat was henceforth termed as the U11 snRNP-binding splicing enhancer 
(USSE). Th is interpretation is also supported by biochemical evidence, in particularly psoralen 
crosslinking and pull-down experiments (I, Figures 2 and 3), which indicate a direct interaction 
between U11 snRNA/snRNP and the USSE element that is sensitive to mutations aff ecting U11 
snRNA/5´ ss base-pairing.
How does the U11 snRNP (or U11/U12 di-snRNP) bind the USSE? Are the U12-type 5´ 
splice sites recognized by a single U11 snRNP or are they bound by two separate snRNPs? A clue 
can be found from the rescue experiment (I, Fig. 4F). Mutation of either one of the 5´ splice sites 
is suffi  cient to abolish alternative splicing. Alternative splicing is restored, however, when two 
diff erent U11 snRNAs are present (one wild-type and one that carries compensatory mutations). 
Here, we would not expect to see a rescue if the duplication serves to increase the affi  nity of a 
single U11 snRNP. Furthermore, alternative splicing is further improved to wild-type levels when 
both U12 5´ ss are mutated, presumably because overexpression of the compensatory mutated 
U11 snRNA now provides optimal stoichiometric conditions for double occupancy. Further 
evidence for the binding of two separate U11 snRNPs at the USSE comes from experiments 
where the length of the spacer region between the two U12-type 5´ splice sites was varied. Here, 
it was found that alternative splicing was signifi cantly reduced when the spacer length was 
shorter than 3 nt and even completely abolished without spacer, arguing for steric hindrance 
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between two snRNPs (II, Fig. 2B). In addition, phylogenetic analysis of spacer length in various 
organisms confi rmed evolutionary pressure to maintain spacer length ≥ 3 nt. 
How does the U11 snRNP activate alternative splicing? Splicing activators are known to 
operate through diff erent mechanisms and one such mechanism is through the inhibition of 
splicing repressors (see 1.2.2.2). Indeed, for both 65K and 48K genes, the USSE is surrounded 
with an extremely conserved sequence that putatively could harbor splicing silencers. In this 
model, U11 snRNP binding would counteract or prevent silencer binding. Another mechanism 
is more direct, acting through the establishment of exon defi nition interactions. However, such 
interactions are generally mediated through the RS domains present in SR and SR-like proteins. 
Th e U11 snRNP contains one candidate SR-like protein, the U1-70K homologue U11-35K. 
In a 3´ UTR reporter construct, the USSE was removed and replaced by BoxB RNA hairpin 
sequences. Th ese structures can tether λN-peptide fusion proteins (Gehring et al., 2008) and, 
in this way, we evaluated the role of the U11-35K in splicing activation. We demonstrated that 
the RS domain of U11-35K is both necessary and suffi  cient for upstream 3´ ss activation (II, 
Fig. 3G), supporting a model in which U11-35K participates in cross-exon communication 
between the two diff erent spliceosomes. I further showed that the activity of the U11-35K is 
comparable to that of the SR protein SRSF1 but less eff ective than U1-70K, which contains 
two RS domains (II, Fig. 3H). Further evidence for an exon defi nition mediated activation of 
alternative splicing came from experiments with constructs where the distance between the 3´ ss 
and its downstream USSE was manipulated. Steric hindrance imposes a minimum limit on exon 
defi nition (Dominski and Kole, 1991), and similarly, gradual reduction from the 65K 3´ ss-USSE 
wild type distance of 43 nt showed a linear decline in alternative splicing (II, Fig. 1C), consistent 
with classical exon defi nition interactions. Furthermore, the 3´ ss-USSE distances in both 48K 
and 65K were highly constrained in terrestrial vertebrates and indicate an exon defi nition model 
in all studied organisms. Th e USSE thus acts as an ESE but, unlike a classical splicing enhancer, 
its relative positioning to the activated 3´ ss is restricted by distance requirements imposed by 
exon defi nition.  
4.3  Alterna? ve splicing leads to a mul? layered inhibitory 
mechanism for 48K and 65K mRNA expression (I and III)
Having gained insight in the mechanism of USSE coupled alternative splicing, we turned our 
attention to the essence of the alternative splicing event itself. Alternative splicing oft en leads 
to the production of alternate protein products but, coupled with NMD or other degradation 
pathways, it can be a mechanism to regulate mRNA levels (RUST: see 1.2.4.1). Here, a gene is 
transcribed and spliced, only to be degraded. Seemingly wasteful, it can however provide an 
extra layer of regulation that is benefi cial to the organism. If the splicing regulator is the protein 
product of the gene itself, an auto-regulatory feedback loop is established. We were left  with an 
interesting hypothesis: could the presence of the USSE, given the affi  nity of the U11-48K protein 
and the U11 snRNP for such sequences, provide the basis for a negative auto-regulatory feedback 
loop? In this case, the expression of two key proteins of the minor spliceosome would be under 
control of the USSE through RUST.  
Both 48K alternate isoforms constitute potential NMD targets: incorporation of the 8 nt 
“poison” exon, as well as the 1852 nt giant exon are predicted to generate PTCs. Indeed, when 
treating cells with the translation inhibitor cycloheximide (CHX), I observed stabilization for 
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the mini-exon containing transcript, and knock-down of the NMD factor Upf1 showed a similar 
result (I, Figures 5B and F). However, the 48K long exon containing isoform was unresponsive 
to CHX treatment (Turunen et al., 2013b). Similarly, the 65K long isoform did not prove to be 
a target for NMD (I, Fig. 5F), even though the presence of a long 3´ UTR has the potential to 
mark the transcript for NMD (Muhlrad and Parker, 1999). Interestingly, a cellular fractionation 
experiment showed an overabundance of the long isoform in comparison to the short isoform 
in the nuclear fraction (I, Fig. 5H) and thus, the 65K long isoform is either subjected to fast 
cytoplasmic decay or retained in the nucleus. In fact, treatment with the transcription inhibitor 
5,6-dichloro-1-beta-D-ribo-furanosylbenzimidazole (DRB) indicated that the 65K long isoform 
was as stable as the short isoform with an estimated half-life of ca. 10h (III, Fig. 1G), ruling out 
active degradation of the mRNA. Using single molecule FISH, I confi rmed nuclear retention of 
the 65K long isoform (III, Fig. 1C) and morpholino blocking of the 65K USSE led to enhanced 
nuclear export (III, Fig. 1D). I then performed a cellular fractionation and showed that a nuclear 
retention mechanism also exists for the 48K transcript with the long exon (III, Fig. 1H). 
What could be the mechanism for nuclear retention? In the case of the 65K mRNA, EST 
data, RNAseq data from ENCODE and a database for conjoined genes (Prakash et al., 2010) 
revealed transcription from the 65K locus into the downstream AMY2B locus connected 
through an intergenic exon (III, Fig. 2A). Th rough manipulation of the 65K splicing pattern 
by USSE blocking morpholinos and careful quantifi cation of the intergenic exon signal by 
qPCR, I deduced that read-through transcription past the 65K poly(A) site was predominantly 
associated with the long isoform (III, Figures 2B and C). Th is off ers a potential mechanism for 
nuclear retention as transcripts with CP defects are oft en retained at the transcription site, and 
furthermore, their degradation is slow (de Almeida et al., 2010). Interestingly, for the plant 48K 
gene, neither alternatively splicing of the 3´ UTR nor the complete retention of the intron in 
the 3´ UTR leads to transcriptional read-through (unpublished data). In plants, NMD has been 
shown to occur both for transcripts with long 3´ UTR and for transcripts where splicing takes 
place within the 3´ UTR (Kertesz et al., 2006), off ering a plausible degradation mechanism for 
48K alternate isoforms in plants. 
Th ere is, however, a substantial amount of 65K long isoform for which CP does occur and the 
mRNA spot pattern observed in FISH is inconsistent with retention at the transcription site only 
(III, Figures 1C and 3G). Furthermore, 48K long exon transcripts demonstrate nuclear retention 
even though the 48K USSE is located in an intronic region and not near the constitutive poly(A) 
site. I hypothesized that binding of the USSE by the U11 snRNP (or U11/U12 di-snRNP) would 
constitute a common nuclear retention mechanism for the long isoforms of both 48K and 65K. 
To test this, I made two diff erent reporter constructs: one in which the long 65K 3´ UTR was 
directly cloned and a reporter that contained the full unprocessed 65K 3´ UTR, and therefore 
required U11 snRNP binding to generate the long isoform. Co-transfection of each of these 
constructs with a short 3´ UTR reporter followed by cellular fractionation showed that nuclear 
retention occurred only when U11 binding was required to produce the long isoform (III, Fig. 
4). Th is argues against the presence of cis-acting nuclear retention signals and suggests that the 
retention mechanism is further dependent on splicing. A possible mechanistic explanation is 
that splicing is required to provide mutual exon defi nition interactions that anchor the two U11/
U12 di-snRNPs onto the USSE element. Stable nuclear retention has been shown to occur when 
early spliceosomal complexes have formed but are impeded to undergo the catalytic steps (Hett 
and West, 2014). Similarly, in addition to alternative splicing activation, the USSE could serve 
to recruit a minor spliceosome which, perhaps due to the absence of a suitable U12-type BPS, is 
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prevented to assemble adequately. In the case of the 48K transcript with exon 4i inclusion only, 
such complexes would not be present in the fi nal mRNA due to removal of the USSE by splicing. 
In contrast, both the longer 48K transcript and the 65K long isoform retain the USSE and thus the 
ability to bind U11/U12-di-snRNPs. Previously, E complex factors such as U1-70K and U2AF65 
have been demonstrated to cause nuclear retention for the major spliceosome (Takemura et al., 
2011) and perhaps, analogously, the U11- (or U11/12 di-) snRNPs recruit or are associated with 
specifi c retention factors. 
Th e expression of 48K and 65K mRNA is regulated through RUST. While nuclear retention 
is employed as a shared mechanism, NMD coupled alternative splicing is specifi c for the 48K 
mini-exon transcript, and transcriptional read-through specifi c for the 65K long isoform. While 
at least three diff erent means are used, the regulatory end product is the same: downregulation 
of minor spliceosomal proteins. Th is multilayered inhibitory system is reminiscent of the 
situation in the SRSF1 gene where alternative splicing generates six isoforms that are either 
nuclear retained, degraded by NMD or controlled at the translational level (Sun et al., 2010). Th e 
redundancy of degradation/retention systems might serve as some sort of double locked fail-
safe mechanism or even allow for extra levels of regulations. For instance, nuclear retention of 
isoforms could be regulated so that specifi c signals release the mRNA into the cytoplasm readily 
available for translation, or alternatively, the activity or effi  ciency of the NMD pathway could be 
altered such that alternatively spliced isoforms are stabilized (Smith and Baker, 2015).
4.4  USSE provides nega? ve auto-regula? on for the 48K gene 
and minor spliceosome mediated cross-regula? on for the 
65K gene (I and III)
Overexpression of the U11-48K protein from a construct leads to enhanced inclusion of the 
poisonous 4i mini-exon and thus leads to reduction in the levels of endogenous 48K mRNA (I, 
Fig. 4C). Th is is the hallmark of an auto-regulatory negative feedback mechanism. No eff ect was 
observed for the 65K mRNA when 65K levels were increased through expression constructs. Th e 
65K mRNA splicing pattern, however, was aff ected by knock-down of both U11-48K and U11-
35K proteins and demonstrated a shift  towards the short isoform in combination with a 3- to 
4-fold upregulation of total 65K mRNA levels (I, Fig. 5C). A similar switch in splicing pattern 
was observed when a mutated U11 snRNA was overexpressed (I, Fig. 4E), suggesting that the 
endogenous U11 snRNA was outcompeted for minor spliceosome protein factors. Although we 
could not establish evidence for an auto-regulatory feedback loop in the 65K gene, it is clear 
that extensive cross-regulation by minor spliceosome components does occur. Even more, when 
I overexpressed a P120 minigene, which contains a U12-type intron, I saw an isoform switch 
towards the short isoform in the 65K gene but no change in the 48K splicing pattern (III, Fig. 
5B). Overall, the effi  ciency of endogenous U12-splicing was unaff ected (III, Fig. 5A). I concluded 
that the USSE of 65K is a more sensitive sensor of minor splicing activity and maintains cellular 
homeostasis by increasing the levels of the export-competent short isoform. Intriguingly, the 
U1-C protein, with a similar role as the U11-48K protein but instead recognizing U2-type 5´ 
splice sites, directs NMD-coupled alternative splicing in the U1-70K gene (encoding a functional 
homologue of U11-35K) providing a cross-regulatory system for components of the major 
spliceosome similar to the one we described here for the minor spliceosome (Rosel-Hillgartner 
et al., 2013).    
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Auto-regulation and cross-regulation are common regulatory mechanisms for splicing 
factors, with ultraconserved sequences oft en as key elements (see 1.2.4.1, and Ni et al. (2007), 
Lareau et al. (2007), Lareau and Brenner (2015)), and negative feedback loops are thought to 
dampen noise in transcriptional output and to maintain cellular homeostasis (Becskei and 
Serrano, 2000). Similarly, in our study, the role of the feedback loops that regulate 48K and 65K 
expression seems to be the maintenance of the steady-state levels of the two minor spliceosome 
associated proteins. However, both U11-48K and U11/U12-65K are excellent candidates to alter 
the activity of the minor spliceosome through changes in their protein concentrations. How can 
these changes be achieved in a negative feedback loop? Th e extreme evolutionary conservation 
over several hundred nucleotides near the USSE in mammals and birds indicates that splicing 
decisions might not lie only in the hands of minor spliceosome components. Indeed, for the 
48K USSE, a rather complex network involving hnRNP H1, U1 snRNP and U11 snRNP directs 
alternative splicing (Turunen et al., 2013b). It is entirely possible that, in diff erent tissues or 
physiological states, several splicing activators and repressors could promote or counteract U11 
snRNP binding to the USSE, and thereby contribute to regulation of 48K and 65K expression. 
Even more, one could imagine a splicing activator that promotes 48K or 65K alternative splicing 
in a U11 snRNP-independent way, thereby bypassing the feedback loop and turning a switch to 
change the activity of the minor spliceosome. On the other hand, the negative feedback loop does 
not need to be broken to alter the concentrations of minor spliceosomes. Auto-regulation can be 
modulated by “master” splicing regulators that allow for diff erent steady-state levels of the auto-
regulated proteins between diff erent cell states. In particular, the splicing factor Rbfox2 has been 
shown to tune negative auto-regulation of many RNA-binding proteins both by promoting or 
suppressing NMD, resulting in splicing network shift s (Jangi et al., 2014). Similarly, negative auto-
regulation and cross-regulation of the U11-48K and U11/U12-65K proteins could be modulated 
by splicing regulators, altering their steady state levels at diff erent cell and developmental states.
4.5  Evolu? onary role of the USSE (I,II and III)
Th e presence of the USSE in the plant 48K 3´ UTR indicates that the regulatory mechanism 
predates the divergence of plants and animals revealing an origin for the USSE of more than 1 
billion years old. Th e minimal requirements of the regulatory mechanism are: (a) a duplicated 
U12-type 5´ ss, (b) communication between components of the minor and major spliceosome, 
with the implication that the regulatory system presumably developed when both spliceosome 
systems were present in the same genome, and (c) a quality control system coupled with 
alternative splicing to establish the negative feedback loop. A simple program of alternative 
splicing has been assumed to be present already in LECA (Irimia and Roy, 2014), and the presence 
of NMD in plants (Isshiki et al., 2001) suggests that a NMD system was already present in the last 
common ancestor of plant and animal. Th e regulatory mechanism that we have described here 
strongly suggests RUST already to be in eff ect in LECA.
Negative auto-regulation benefi ts the organism by minimizing potentially toxic fl uctuations 
of gene expression and unnecessary translation (Becskei and Serrano, 2000). For RNA binding 
proteins, and splicing factors in particular, it seems that the evolutionary most facile and 
permissive way to establish auto-regulation is to recognize the RNA of their own genes and 
activate unproductive splicing. Indeed, many non-homologous genes coding for SR proteins, 
hnRNPs and core spliceosome proteins have evolved auto-regulation through unproductive 
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alternative splicing (Saltzman et al., 2008, Lareau and Brenner, 2015). Th e fact that the USSE 
requires two U11 snRNPs for binding might turn it into a particular sensitive enhancer element 
for regulation, enabling detection at low levels of U11 snRNP. Indeed, knock-down of the U11-
48K protein has moderate eff ects on U12-type splicing but a dramatic eff ect on the alternative 
splicing of 65K. 
A look at the phylogenetic distribution of the USSE (I, Fig. 7) reveals that, even though the 
USSE can be found in the plant 48K gene, the USSE in the 65K gene seems to be a relatively recent 
innovation antedating the tetrapod-fi sh divergence and indicates that the regulatory system has 
changed across evolution to include a cross-regulatory mechanism. It is worth noting that among 
the closely related SR proteins, a family which expanded through gene duplication, poison 
cassettes for auto-regulation can be found in non-homologous positions (Lareau et al., 2007). 
Here, ancestral unproductive splicing was rapidly replaced by newly acquired unproductive 
splicing aft er each duplication (Lareau and Brenner, 2015). Th is shows that such regulatory 
elements can be readily acquired during evolution depending on the regulatory requirements 
of the organism and perhaps this has happened for the 65K gene as well. Th e presence of the 
USSE in the 3´ UTRs of vertebrate 65K and plant 48K genes, as compared to within an intron 
in the vertebrate 48K gene, reveals that the regulatory mechanism employs diff erent means of 
degradation to achieve the same regulatory end. 
Could the negative feedback loops serve to down-regulate minor spliceosome proteins to 
limit their availability in minor splicing and thereby contributing to the reduced rate the splicing 
reaction? Th e presence of a similar negative feedback loop for the major spliceosome rather 
suggests that this is a general mechanism to ensure homeostasis of core spliceosome components 
(Rosel-Hillgartner et al., 2013). On the other hand, many splicing factors are auto-regulated but 
their steady state levels can be altered by “master” splicing regulators, enabling their participation 
to diff erent splicing networks. A similar regulation could be the underlying mechanism by 
which the U11-48K and the U11/12-65K proteins aff ect minor splicing in diff erent cellular 
conditions. Interestingly, it seems that in the tetrapod lineage extra regulatory elements were 
installed. Indeed, the DNA sequences that surround the USSE are ultraconserved in mammals 
and sauropsida (birds and reptiles) and potentially constitute many (overlapping) binding sites 
for splicing repressors and activators in a much defi ned setting. 
Finally, there is the possibility that loss of the USSE is related to the loss of U12-type introns 
in many lineages. Loss of minor splicing homeostasis or the ability to regulate the activity of the 
minor spliceosome might relieve the selection pressure for maintaining U12-introns, setting the 
path for U12-type to U2-type conversion.    
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Figure 7. Model of USSE-directed regulation of alternative splicing in the U11-48K and U11/U12-
65K genes, and of the minor spliceosome. (A) An increased level of U11 snRNP leads to downregulation 
of 48K and 65K expression through USSE-directed alternative splicing, creating negative auto-regulatory 
and cross-regulatory feedback loops. Binding of two U11/U12 di-snRNPs at the two U12-type 5´ ss motifs 
promotes activation of an upstream 3´ ss via U11-35K mediated exon defi nition interactions. Exons are 
in blue/green and the 3´ UTR is in yellow. (B) Th e 65K USSE acts as a sensor for minor spliceosome 
activity. Increased minor splicing activity leads to a 65K isoform switch, generating an export competent 
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5.  CONCLUDING REMARKS
In I, I have identifi ed and characterized the ultraconserved element and have shown that it is 
in fact a splicing enhancer element (termed USSE) that requires the U11 snRNP to activate an 
upstream 3´ ss. Th e alternative splicing event that follows produces, in the case of the minor 
spliceosome associated 48K gene, an mRNA isoform that is targeted for destruction. Th e resulting 
“negative auto-regulatory feedback loop” was shown to be evolutionarily ultraconserved as the 
element was found in mammals, fi sh, insects and even plants, and is therefore proposed to carry 
an important function in the regulation of the minor spliceosome. In II, we have characterized 
the U11-35K protein and show that its RS domain is suffi  cient and necessary for exon defi nition 
interactions, acting as a mediator of communication between components of the minor and 
major spliceosome. In addition, by manipulation of distances between the two 5´ ss-like motifs 
and the upstream 3´ ss, we gained insight into the molecular properties of U11 snRNP binding 
and these fi ndings were supported by evolutionary data. In III, I show that in the 65K gene, 
also encoding for a minor spliceosome associated protein and containing a USSE element in its 
3´ UTR, alternative splicing produces a splice product which is, as shown by cell fractionation 
experiments and fl uorescence in situ hybridization (FISH), retained in the nucleus. Th e nuclear 
retention requires the binding of the U11 snRNP. Additionally, I demonstrated that cleavage/
polyadenylation of the alternative isoform is compromised and propose a mechanism that 
explains this fi nding. Figure 7 summarizes the main fi ndings of this thesis. 
Overall, the regulatory feedback loop that I have characterized in this study serves to 
maintain an appropriate balance for minor spliceosome proteins and could provide a framework 
for further studies into the regulation of the minor spliceosome. Additionally, this study opens 
an intriguing possibility that USSE-directed non-productive alternative splicing is further fi ne-
tuned by other splicing factors, regulating the expression of both U11-48K and U11/U12-65K 
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